<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26896" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Penile Cancer and Penile Intraepithelial Neoplasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Engelsgjerd</surname>
            <given-names>Joshua S.</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>LaGrange</surname>
            <given-names>Chad A.</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joshua Engelsgjerd declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chad LaGrange declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26896.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Penile cancer is an uncommon malignancy, but when diagnosed, it is psychologically devastating to the patient and can pose a challenge to clinicians. Patients with this condition tend to delay seeking medical attention as the lesion is usually painless, resulting in self-medication attempts before diagnosis. This delay is also associated with embarrassment, guilt, fear, and denial by the patient and&#x000a0;can significantly affect survival rates, morbidity, and postsurgical outcomes. The overall risk of penile cancer in the United States is 1&#x000a0;in 100,000 or less. Risk factors for the development of penile cancer include phimosis, uncircumcised state, poor genital hygiene, human papillomavirus infection, and smoking. Initial treatment of early-stage disease is surgical and has a good prognosis. When the condition is more advanced, inguinal lymphadenectomy may be needed, which has considerable morbidity.&#x000a0;</p>
        <p>Penile intraepithelial neoplasia is the term now used for premalignant penile skin lesions. These lesions were formerly classified separately as Bowenoid papulosis, Bowen disease, erythroplasia of Queryrat, and squamous cell carcinoma in situ of the penis.&#x000a0;</p>
        <p>This activity for healthcare professionals reviews the spectrum of penile cancer, primarily focusing on squamous cell carcinoma, the most prevalent penile malignancy. The etiology, epidemiology, histopathology, diagnosis, staging, and follow-up protocols of penile cancer are also reviewed. The activity addresses various treatment modalities, emphasizing the importance of an effective interprofessional approach to managing this condition to improve patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the typical clinical manifestations of penile cancer, including lesion characteristics and associated symptoms.</p></list-item><list-item><p>Implement evidence-based guidelines for the initial workup of suspected penile cancer, incorporating diagnostic procedures and staging evaluations.</p></list-item><list-item><p>Assess&#x000a0;various treatment modalities available for penile cancer, including surgical, radiation, chemotherapy, and immunotherapy options.</p></list-item><list-item><p>Communicate clearly and effectively within&#x000a0;an interprofessional team to ensure a shared understanding of patient needs and treatment plans to improve outcomes for patients affected by penile cancer.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26896&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26896">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26896.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Penile cancer&#x000a0;is an uncommon malignancy that is psychologically devastating to the patient and can pose a challenge to clinicians. Patients with this condition tend to delay seeking medical attention due to embarrassment, guilt, fear, neglect, and denial.<xref ref-type="bibr" rid="article-26896.r1">[1]</xref><xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r3">[3]</xref>&#x000a0;Additionally, the lesions are generally painless and do not typically cause erectile dysfunction or voiding difficulties in their early stages.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref>&#x000a0;</p>
        <p>Patients often attempt to self-medicate with lotions, creams, or salves before seeking care. Up to 50% of patients with penile cancers will have delayed seeking medical attention for the lesion for up to&#x000a0;1 year. The delays in treatment may also be partly attributable to clinicians, as an estimated 25% of penile malignancies are diagnosed initially as benign lesions.</p>
        <p>Many patients receive ointments, salves, and antibiotics from their clinician before seeing a urologist or dermatologist. The COVID-19 pandemic exacerbated this problem, especially as virtual visits are notoriously inadequate in evaluating penile lesions and possible carcinoma.<xref ref-type="bibr" rid="article-26896.r4">[4]</xref>&#x000a0;This delay in diagnosis is quite&#x000a0;serious, as it can decrease the likelihood of survival, increase morbidity, and limit the ability to retain a functioning, satisfactory result after surgical intervention.<xref ref-type="bibr" rid="article-26896.r5">[5]</xref><xref ref-type="bibr" rid="article-26896.r6">[6]</xref><xref ref-type="bibr" rid="article-26896.r7">[7]</xref><xref ref-type="bibr" rid="article-26896.r8">[8]</xref></p>
        <p>The most common penile malignancy is squamous cell carcinoma, but nonsquamous malignant neoplasms of the penis also exist, including basal cell carcinomas, melanomas, sarcomas, metastatic cancers, and adenosquamous carcinomas.&#x000a0;Premalignant penile lesions, formerly called&#x000a0;Bowenoid papulosis, Bowen disease, erythroplasia of Queryrat, and squamous cell carcinoma in situ of the penis, are now classified as penile intraepithelial neoplasia. Bowenoid papulosis is often classified separately by dermatologists due to its generally benign and self-limiting course with a close clinical similarity to genital warts, even though histologically, it more closely resembles squamous cell carcinoma in situ.<xref ref-type="bibr" rid="article-26896.r9">[9]</xref> For more details on Bowenoid papulosis, see the companion StatPearls review on&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/116917">Bowenoid Papulosis</ext-link>."<xref ref-type="bibr" rid="article-26896.r9">[9]</xref></p>
        <p>This activity focuses primarily on squamous cell carcinoma, including its etiology, epidemiology, pathophysiology, histopathology, evaluation, differential diagnosis, and treatment. The importance of the primary tumor's pathologic stage and histologic features, as well as the presence of lymph node metastases, in determining prognosis and treatment planning for squamous cell carcinoma are discussed.&#x000a0;Treatment options and appropriate follow-up&#x000a0;are covered&#x000a0;in depth.</p>
      </sec>
      <sec id="article-26896.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The incidence of penile cancer varies and is related to several factors. Clinicians have identified risk factors, including a history of phimosis, balanitis, chronic inflammation, penile trauma, lack of neonatal circumcision, tobacco use, balanitis xerotica obliterans, poor genital hygiene, and a history of sexually transmitted infections (STIs), especially human immunodeficiency virus (HIV) and human papillomavirus (HPV).<xref ref-type="bibr" rid="article-26896.r10">[10]</xref><xref ref-type="bibr" rid="article-26896.r11">[11]</xref><xref ref-type="bibr" rid="article-26896.r12">[12]</xref>&#x000a0;For example,&#x000a0;patients who smoke cigarettes are 3 to 4.5 times more likely to develop penile cancer than those who do not.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref></p>
        <p>Neonatal circumcision has&#x000a0;been correlated&#x000a0;with much lower rates of penile cancer.<xref ref-type="bibr" rid="article-26896.r14">[14]</xref>&#x000a0;Further, it has been established as an excellent prophylactic measure that can virtually eliminate the later development of penile carcinoma.<xref ref-type="bibr" rid="article-26896.r15">[15]</xref><xref ref-type="bibr" rid="article-26896.r16">[16]</xref><xref ref-type="bibr" rid="article-26896.r17">[17]</xref>&#x000a0;This rate reduction can be attributed to the fact that circumcision eliminates the closed preputial environment where penile carcinoma develops. Elimination of the closed environment has&#x000a0;several benefits, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prevention of the chronic irritative effects of smegma, which can lead to chronic inflammation, a known risk factor for penile cancer; smegma itself is not directly considered a causative agent of malignancy.</p>
          </list-item>
          <list-item>
            <p>Elimination of the possibility of phimosis, paraphimosis, balanitis, and&#x000a0;balanoposthitis.<xref ref-type="bibr" rid="article-26896.r18">[18]</xref><xref ref-type="bibr" rid="article-26896.r19">[19]</xref>&#x000a0;Patients with a history of phimosis have an increased risk for penile cancer of 25% to 60%, most likely due to the poor genital hygiene associated with this condition.<xref ref-type="bibr" rid="article-26896.r14">[14]</xref><xref ref-type="bibr" rid="article-26896.r20">[20]</xref></p>
          </list-item>
        </list>
        <p>Population-based studies support that neonatal circumcision can be an effective prophylactic measure against penile cancer.<xref ref-type="bibr" rid="article-26896.r15">[15]</xref><xref ref-type="bibr" rid="article-26896.r21">[21]</xref><xref ref-type="bibr" rid="article-26896.r22">[22]</xref>&#x000a0;For example, there is an exceedingly low incidence of penile cancer in the Jewish population (9 case reports in the world medical literature), where neonatal circumcision is a universal practice.<xref ref-type="bibr" rid="article-26896.r23">[23]</xref><xref ref-type="bibr" rid="article-26896.r22">[22]</xref>&#x000a0;Further evidence is the reported incidence of penile cancer in India, where circumcision is uncommon, is 3.32 per 100,000 men compared to the rate in Jewish individuals living in Israel, where the disease prevalence is virtually zero.<xref ref-type="bibr" rid="article-26896.r23">[23]</xref>&#x000a0;</p>
        <p>In countries where circumcisions are performed later in infancy, the incidence of penile cancer increases.<xref ref-type="bibr" rid="article-26896.r21">[21]</xref><xref ref-type="bibr" rid="article-26896.r24">[24]</xref><xref ref-type="bibr" rid="article-26896.r25">[25]</xref>&#x000a0;African and Asian cultures that do not routinely perform circumcision have much higher rates of penile cancer, which accounts for 10% to 20% of all malignant neoplasms in men in these ethnic groups.<xref ref-type="bibr" rid="article-26896.r22">[22]</xref>&#x000a0;STIs&#x000a0;are also noted&#x000a0;to be a risk factor for the development of penile cancer, particularly HIV and HPV. Patients with HIV have an 8-fold increased risk for the development of penile cancer, which can&#x000a0;be reduced&#x000a0;by circumcision.</p>
        <p>The percent of penile cancers related to HPV is about 60% (range: 45% to 80%), with a&#x000a0;strong&#x000a0;correlation to HPV types 6, 18, and particularly 16.<xref ref-type="bibr" rid="article-26896.r26">[26]</xref><xref ref-type="bibr" rid="article-26896.r27">[27]</xref>&#x000a0;High-risk HPV is much more common in men with a history of phimosis. A positive HPV status may be suggestive of a higher cancer sensitivity to radiation therapy and a better overall prognosis.<xref ref-type="bibr" rid="article-26896.r28">[28]</xref><xref ref-type="bibr" rid="article-26896.r29">[29]</xref>&#x000a0;Sexual activity increases the risk of penile cancer, probably through increased HPV transmission.<xref ref-type="bibr" rid="article-26896.r26">[26]</xref>&#x000a0;The increased use of HPV vaccines will hopefully help reduce the incidence of this cancer.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref></p>
        <p>Overall, the&#x000a0;strongest&#x000a0;risk factors for penile cancer are high-risk HPV infection, phimosis, and smoking.<xref ref-type="bibr" rid="article-26896.r30">[30]</xref>&#x000a0;Other reported risk factors include chronic rashes involving the penis lasting at least&#x000a0;1&#x000a0;month, late or delayed circumcision, uncircumcised state, obesity, urinary tract infections, genital warts, lichen sclerosus (balanitis xerotica obliterans), poor personal hygiene, and a history of urethral strictures.<xref ref-type="bibr" rid="article-26896.r21">[21]</xref><xref ref-type="bibr" rid="article-26896.r31">[31]</xref>&#x000a0;</p>
        <p>Failure to use condoms regularly doubles the risk of penile cancer.<xref ref-type="bibr" rid="article-26896.r32">[32]</xref>&#x000a0;An immunocompromised state also increases the risk. Men with renal transplant are 17 times more likely to develop penile cancer than the general population, compared to just 2 to 3 times the risk of other cancers in this immunocompromised population.<xref ref-type="bibr" rid="article-26896.r33">[33]</xref><xref ref-type="bibr" rid="article-26896.r34">[34]</xref></p>
        <p>Psoralen plus ultraviolet A (PUVA) photochemotherapy is a commonly used treatment for chronic plaque psoriasis.<xref ref-type="bibr" rid="article-26896.r35">[35]</xref>&#x000a0;PUVA exposure has been associated with a higher rate of cutaneous squamous cell carcinoma, even in unexposed skin areas, including the genitals. The long-term risk of penile cancer in patients treated with PUVA, even with shielding of the genitals, is almost 100 times higher than in the general population and appears to be dose-related.<xref ref-type="bibr" rid="article-26896.r35">[35]</xref><xref ref-type="bibr" rid="article-26896.r36">[36]</xref><xref ref-type="bibr" rid="article-26896.r37">[37]</xref><xref ref-type="bibr" rid="article-26896.r38">[38]</xref></p>
      </sec>
      <sec id="article-26896.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Worldwide, 36,068 new cases of penile cancer&#x000a0;were diagnosed&#x000a0;in 2020, according to the International Agency for Research on Cancer.<xref ref-type="bibr" rid="article-26896.r30">[30]</xref>&#x000a0;Most of these cases (95%) were squamous cell carcinomas.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref>&#x000a0;Penile cancer is more common in resource-limited areas of the world, such as Africa, Asia, and South America. In these areas, penile cancer can account for up to 10% to 20% of all malignancies in men. The increased risk in these regions may be due to differences in hygiene practices, HPV and HIV infections, and the large numbers of uncircumcised men.<xref ref-type="bibr" rid="article-26896.r30">[30]</xref>&#x000a0;</p>
        <p>The highest incidence is in South America, followed by the Caribbean.&#x000a0;The state of Maranh&#x000e3;o in Northeast Brazil has the highest reported incidence of penile cancer in the world, thought to be due to its high rate of HPV infections.<xref ref-type="bibr" rid="article-26896.r39">[39]</xref>&#x000a0;Other countries with very high rates of penile cancer include Botswana, Bolivia, Colombia, Paraguay, Uganda, and Venezuela. The highest mortality rates are in South-Central Asia and Eastern Africa.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref>&#x000a0;</p>
        <p>Penile cancer&#x000a0;is a malignancy that is rare in resource-rich areas of the world. This condition accounts for less than 1% of cancers in men in the United States, with just over 2000 new cases and 500 deaths annually.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref><xref ref-type="bibr" rid="article-26896.r40">[40]</xref>&#x000a0;The average age-adjusted prevalence in the United States is 0.81 cancers per 100,000 men per year, which increases steadily with age.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref>&#x000a0;</p>
        <p>There is no difference in the incidence between White and Black populations, but Black and Hispanic individuals tend to&#x000a0;be diagnosed&#x000a0;at a younger age. Black patients also have a higher mortality rate from this malignancy.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref>&#x000a0;The incidence in Hispanic populations is 72% higher than in non-Hispanic; Asians and Pacific Islanders have double the incidence of the general population.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref>&#x000a0;The overall prevalence of penile cancer has decreased in the United States over the last&#x000a0;3&#x000a0;decades of the 20th century.<xref ref-type="bibr" rid="article-26896.r41">[41]</xref>&#x000a0;</p>
        <p>Interestingly, the National Cancer Database found that between 1998 and 2012, the incidence of all stages of squamous penile cancer increased with a&#x000a0;greater&#x000a0;proportion of advanced cases over time. The disease is associated with older age, with the mean age of diagnosis being approximately 60 years old.<xref ref-type="bibr" rid="article-26896.r30">[30]</xref>&#x000a0;Higher incidence rates are also reported in areas of lower socioeconomic status and&#x000a0;states located in the Southern United States.<xref ref-type="bibr" rid="article-26896.r13">[13]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26896.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Penile cancers traditionally begin as small painless lesions, nodules, lumps, or ulcers, typically on the glans penis or prepuce. The appearance can vary greatly. Some appear as white-grey exophytic masses growing out of the penile skin; others can be flat, reddish-colored, or ulcerated.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r42">[42]</xref>&#x000a0;These lesions grow slowly laterally along the surface of the penile skin and often cover the entire glans or prepuce before invading the corpora and shaft of the penis.&#x000a0;</p>
        <p>Growth rates of ulcerative versus exophytic lesions are similar, although ulcerative lesions appear to metastasize to lymph nodes earlier. Penile lymphatics drain both the glans penis and shaft. Drainage proceeds first to the superficial inguinal lymph nodes, then to the deep inguinal nodes, before proceeding to the external iliac lymphatics in the pelvis.<xref ref-type="bibr" rid="article-26896.r43">[43]</xref><xref ref-type="bibr" rid="article-26896.r44">[44]</xref></p>
        <p>Penile intraepithelial neoplasia&#x000a0;(PIN) describes precancerous penile dermatoses where the epithelium displays dysplastic changes with an intact basement membrane.<xref ref-type="bibr" rid="article-26896.r45">[45]</xref>&#x000a0;This term replaces erythroplasia of Queyrat, Bowen disease, and squamous cell carcinoma in situ of the penis.<xref ref-type="bibr" rid="article-26896.r46">[46]</xref>&#x000a0;Bowenoid papulosis is sometimes included but is considered a benign lesion and classified as a separate entity.<xref ref-type="bibr" rid="article-26896.r9">[9]</xref>&#x000a0;For more details on Bowenoid papulosis, see the companion StatPearls review on "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/116917">Bowenoid Papulosis</ext-link>."<xref ref-type="bibr" rid="article-26896.r9">[9]</xref></p>
        <p>All penile intraepithelial neoplastic lesions are now considered high-grade, and about 2% will progress to squamous cell carcinoma without treatment.<xref ref-type="bibr" rid="article-26896.r47">[47]</xref>&#x000a0;This type of dermatosis is the most common premalignant lesion of the penis and is&#x000a0;often associated with skin disorders of the glans and foreskin, such as lichen planus, balanoposthitis, phimosis, lichen sclerosus (balanitis xerotica obliterans), and genital warts, as well as immunosuppressive drug use and organ transplantation.<xref ref-type="bibr" rid="article-26896.r48">[48]</xref></p>
      </sec>
      <sec id="article-26896.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Confirmation of the diagnosis of penile cancer and assessment of the depth of invasion, the presence of vascular invasion, and histological grade of the lesion by microscopic examination of a biopsy specimen are mandatory before initiation of therapy. Vascular invasion by tumor cells has significant prognostic importance, and it is essential that the pathologist comment on the presence or absence of vascular invasion in the surgical specimen. Perineural invasion is another strong predictor of regional and distant lymph node metastases.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref></p>
        <p>Squamous cell carcinoma is by far the most common penile malignancy, accounting for over 95% of cases, and is&#x000a0;characterized and subclassified by microscopic histologic features.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r13">[13]</xref>&#x000a0;Subtypes include the usual type of squamous cell carcinoma (45% to 65%), papillary carcinoma (2% to 15%), warty condylomatous tumors (7% to 10%), basaloid carcinoma (4% to 10%), verrucous carcinoma (3% to 7%), and sarcomatoid (spindle cell) carcinoma (1% to 6%).<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r13">[13]</xref><xref ref-type="bibr" rid="article-26896.r49">[49]</xref>&#x000a0;</p>
        <p>The usual type of squamous cell carcinoma demonstrates keratinization, epithelial pearl formation, and various degrees of mitotic activity. Invasive lesions infiltrate the basement membrane and surrounding structures. Squamous cell carcinomas have been classically graded using the Broder classification or the World Health Organization system, which defines the level of differentiation based on keratinization, nuclear pleomorphism, number of mitoses, and other features.<xref ref-type="bibr" rid="article-26896.r50">[50]</xref></p>
        <p><bold>Low-grade lesions</bold>&#x000a0;</p>
        <p>Low-grade lesions&#x000a0;(grades 1 and 2) constitute 70% to 80% of all reported cases of penile cancer at diagnosis. Well-differentiated lesions show cords of atypical squamous cells projecting downward from a hyperkeratotic epidermis. Tumor cells form an irregular pattern with minimal intervening stroma.</p>
        <p>
<bold>High-grade l<bold>esions&#x000a0;</bold></bold>
</p>
        <p>High-grade lesions&#x000a0;(poorly differentiated) demonstrate poor keratinization, hyperchromatic nuclei in polymorphic tumor cells, frequent mitoses, and a significant stromal reaction. Numerous studies have associated high-grade penile cancer with regional nodal metastases.</p>
        <p>Penile intraepithelial neoplasia&#x000a0;may display varying degrees of dysplasia, keratin, nuclear atypia, and cellular differentiation.<xref ref-type="bibr" rid="article-26896.r47">[47]</xref><xref ref-type="bibr" rid="article-26896.r51">[51]</xref>&#x000a0;This condition may be related to HPV (found in over 90% of PIN, usually seen on the glans and associated with undifferentiated PIN) or unrelated (typically located on the foreskin and associated with differentiated PIN and lichen sclerosis).<xref ref-type="bibr" rid="article-26896.r50">[50]</xref><xref ref-type="bibr" rid="article-26896.r52">[52]</xref></p>
      </sec>
      <sec id="article-26896.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Penile cancer most often presents with a painless ulcerative skin lesion or palpable nodule on the penis.<xref ref-type="bibr" rid="article-26896.r53">[53]</xref>&#x000a0;A rash, bleeding, or apparent balanitis are less common presentations.<xref ref-type="bibr" rid="article-26896.r53">[53]</xref>&#x000a0;Lesions commonly&#x000a0;arise on the&#x000a0;glans,&#x000a0;coronal sulcus, or prepuce. A review of penile squamous cell cancers in the United States showed that 34.5% of patients had the primary lesion on the glans, 13.2% on the prepuce, 5.3% on the shaft, 4.5%&#x000a0;overlapping, and 42.5% were unspecified.</p>
        <p>Inguinal lymphadenopathy is present in 30% to 60% of cases at the initial diagnosis, but only&#x000a0;about half will show nodal evidence of malignancy.<xref ref-type="bibr" rid="article-26896.r54">[54]</xref>&#x000a0;Distant metastases are uncommon until late in the course of the disease as vascular invasion is rare, probably due to Buck fascia acting as a barrier.<xref ref-type="bibr" rid="article-26896.r55">[55]</xref>&#x000a0;Only 1% to 10% of cases will have distant metastases at the&#x000a0;time of presentation, usually to bone, liver, lung, or brain.<xref ref-type="bibr" rid="article-26896.r56">[56]</xref>&#x000a0;Such cases will almost always have inguinal nodal involvement.</p>
      </sec>
      <sec id="article-26896.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Initial evaluation of men with a penile mass or ulcer depends on whether the clinical presentation is consistent with an infectious etiology or malignancy. In cases where infection seems more likely, a 4-week course of antifungals or antibiotics&#x000a0;is appropriate, with a repeat clinical exam at the end of treatment. If the lesion does not resolve or progresses, a biopsy is indicated.<xref ref-type="bibr" rid="article-26896.r57">[57]</xref><xref ref-type="bibr" rid="article-26896.r58">[58]</xref>&#x000a0;Common dermoscopic features of penile intraepithelial neoplasia include areas without structure, vascularity, dotted vessels, absence of pigment, scan, scarred areas, erosions, and brownish-grey spots and globules.<xref ref-type="bibr" rid="article-26896.r59">[59]</xref></p>
        <p>Suspicion for penile carcinoma should be high in men who present with a painless penile mass or ulcer, especially if they are uncircumcised. A tissue biopsy is required for a definitive pathologic diagnosis and is necessary before the initiation of any definitive cancer therapy. A biopsy can&#x000a0;be performed&#x000a0;using a punch, incisional, or excisional technique.&#x000a0;A magnetic resonance image (MRI) of the penis can be beneficial in determining the depth of invasion of a penile malignancy into the corpora&#x000a0;cavernosum&#x000a0;or spongiosum.<xref ref-type="bibr" rid="article-26896.r60">[60]</xref>&#x000a0;An excisional biopsy is appropriate if the lesion can&#x000a0;be removed&#x000a0;in its entirety with little or no alteration in penile function.</p>
        <p>If the biopsy is positive for cancer, an extensive physical examination of the regional lymph nodes&#x000a0;is indicated. Penile cancer initially spreads to the superficial inguinal lymph nodes, deep inguinal nodes, pelvic lymphatics, and then to the retroperitoneal nodes. The inguinal lymph nodes should be carefully examined, with attention paid to the location, size, and number of palpable nodes and whether they are fixed or mobile. The presence or absence of lymph nodal involvement is&#x000a0;extremely important&#x000a0;as it dictates treatment and provides important prognostic information.<xref ref-type="bibr" rid="article-26896.r58">[58]</xref></p>
        <p>Unfortunately, the clinical assessment of inguinal lymph nodes is not entirely reliable. False-negative clinical evaluations of the inguinal region by palpation alone are&#x000a0;common, reportedly between 9% and 60% of cases. False-positive assessments are also frequent. For this reason, imaging&#x000a0;is often obtained&#x000a0;in conjunction with a clinical exam. Computed tomography (CT) scan, MRI, or inguinal ultrasound can&#x000a0;be used, as well as positron emission tomography (PET) scans.<xref ref-type="bibr" rid="article-26896.r61">[61]</xref>&#x000a0;However, even optimal imaging can miss micrometastatic spread to the lymph nodes, which occurs in about one-quarter of all cases.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref>&#x000a0;This is why a histological examination of lymphatic tissue is needed and essential for proper staging in higher-risk individuals.</p>
        <p>HPV status should also be determined. The potential role of various viral and immune biomarkers in diagnosing and treating penile cancer is still evolving.<xref ref-type="bibr" rid="article-26896.r62">[62]</xref>&#x000a0;Pathological staging is necessary for men with palpable lymphadenopathy and for those who are at high risk for metastases based on the pathological features of the primary tumor. The nodes can be evaluated by ultrasound-guided fine-needle aspiration, dynamic sentinel node biopsy, or an inguinal lymph node dissection (superficial or modified).<xref ref-type="bibr" rid="article-26896.r63">[63]</xref><xref ref-type="bibr" rid="article-26896.r64">[64]</xref><xref ref-type="bibr" rid="article-26896.r65">[65]</xref>&#x000a0;See StatPearls companion reference reviews, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/116917">Lymph Node Dissection</ext-link>"&#x000a0;and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/18301">Fine Needle Aspiration</ext-link>," for more information on these procedures.<xref ref-type="bibr" rid="article-26896.r63">[63]</xref><xref ref-type="bibr" rid="article-26896.r64">[64]</xref>&#x000a0;</p>
        <p>Patients at high risk for cancer in the regional lymph nodes should undergo a chest x-ray, CT scan of the abdomen and pelvis, and blood tests, including serum calcium and liver function tests. A bone scan should&#x000a0;be performed&#x000a0;if the patient complains of bone pain, has hypercalcemia, or has an elevated serum alkaline phosphatase.<xref ref-type="bibr" rid="article-26896.r66">[66]</xref>&#x000a0;PET&#x000a0;and CT scans are&#x000a0;sensitive&#x000a0;imaging tools for detecting metastases in selected cases.<xref ref-type="bibr" rid="article-26896.r67">[67]</xref><xref ref-type="bibr" rid="article-26896.r68">[68]</xref></p>
      </sec>
      <sec id="article-26896.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Penile Intraepithelial Neoplasia&#x000a0;</bold>
</p>
        <p>Most premalignant lesions (Bowen disease, erythroplasia of Queyrat, and squamous cell carcinoma in situ of the penis)&#x000a0;are now classified&#x000a0;as penile intraepithelial neoplasia.</p>
        <p><bold>Bowen disease:</bold>&#x000a0;Clinically, this condition appears as discrete, scaly, erythematous plaques or patches.<xref ref-type="bibr" rid="article-26896.r69">[69]</xref>&#x000a0;Histologically, it is a squamous cell carcinoma in situ of the penile shaft.&#x000a0;Ten percent of men with Bowen disease eventually develop invasive squamous cell carcinoma. Treatment includes topical therapy, wide local excision, and laser ablation/excision.<xref ref-type="bibr" rid="article-26896.r70">[70]</xref>&#x000a0;</p>
        <p><bold>Bowenoid papulosis:</bold>&#x000a0;This condition is often similar to small genital warts on the glans or shaft skin of the penis and can range from individual papules to maculopapular plaques that may be erythematous, velvety, pigmented red-brown-purplish, or even appears as a white, warty patch.<xref ref-type="bibr" rid="article-26896.r9">[9]</xref><xref ref-type="bibr" rid="article-26896.r69">[69]</xref>&#x000a0;The penile shaft is involved most often. Bowenoid papulosis is usually asymptomatic but may become pruritic and is highly contagious.&#x000a0;HPV 16 has&#x000a0;been closely identified with these lesions.<xref ref-type="bibr" rid="article-26896.r71">[71]</xref>&#x000a0;Patients are typically sexually active and younger than those with Bowen disease or erythroplasia of Queryat.<xref ref-type="bibr" rid="article-26896.r69">[69]</xref>&#x000a0;</p>
        <p>The lesions are usually benign but may rarely progress to cancer or Bowen disease.<xref ref-type="bibr" rid="article-26896.r72">[72]</xref><xref ref-type="bibr" rid="article-26896.r73">[73]</xref><xref ref-type="bibr" rid="article-26896.r74">[74]</xref><xref ref-type="bibr" rid="article-26896.r75">[75]</xref>&#x000a0;Treatment is surveillance, topical 5-fluorouracil, laser vaporization, cryotherapy, or photodynamic therapy with 5-aminolevulinic acid activation.<xref ref-type="bibr" rid="article-26896.r9">[9]</xref>&#x000a0;See the StatPearls companion reference review,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/www.statpearls.com/point-of-care/18487">Bowenoid Papulosis</ext-link>, for more information.<xref ref-type="bibr" rid="article-26896.r9">[9]</xref></p>
        <p><bold>Buschke-Lowenstein tumor, giant condyloma:</bold>&#x000a0;This lesion presents as an exophytic cauliflower-like mass in the genital or anorectal lesion&#x000a0;and can be locally invasive.<xref ref-type="bibr" rid="article-26896.r76">[76]</xref>&#x000a0;HPV 6 and HPV 11 have&#x000a0;been found&#x000a0;in these tumors.<xref ref-type="bibr" rid="article-26896.r76">[76]</xref>&#x000a0;Progression to invasive squamous cell carcinoma&#x000a0;is reported&#x000a0;in 30% to 57%.<xref ref-type="bibr" rid="article-26896.r77">[77]</xref><xref ref-type="bibr" rid="article-26896.r78">[78]</xref><xref ref-type="bibr" rid="article-26896.r79">[79]</xref>&#x000a0;Treatment is surgical excision.<xref ref-type="bibr" rid="article-26896.r76">[76]</xref>&#x000a0;See StatPearls&#x02019; companion reference,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/111964">Giant Condyloma Acuminata of Buschke and Lowenstein</ext-link>, for more information.<xref ref-type="bibr" rid="article-26896.r76">[76]</xref></p>
        <p><bold>Cutaneous penile horn:</bold>&#x000a0;This lesion typically develops over another skin lesion (eg, abrasion, nevus, wart) and is characterized by significant epithelial cornification and overgrowth that results in a solid skin projection.<xref ref-type="bibr" rid="article-26896.r80">[80]</xref>&#x000a0;This is a rare lesion often associated with HPV 16; a significant percentage of these (37%) involve an underlying malignancy.<xref ref-type="bibr" rid="article-26896.r81">[81]</xref>&#x000a0;Progression to overt penile cancer has been reported.<xref ref-type="bibr" rid="article-26896.r82">[82]</xref><xref ref-type="bibr" rid="article-26896.r83">[83]</xref>&#x000a0;</p>
        <p><bold>Erythroplasia of Queyrat:</bold>&#x000a0;This lesion usually presents as a well-demarcated area on the glans or foreskin with a red, velvety appearance.<xref ref-type="bibr" rid="article-26896.r69">[69]</xref>&#x000a0;Histologically, it is a carcinoma-in-situ of the foreskin or glans. Up to 10% of men with this disorder may eventually develop invasive squamous cell carcinoma of the penis. Treatment includes topical therapy, wide local excision, and laser ablation&#x000a0;or excision.<xref ref-type="bibr" rid="article-26896.r70">[70]</xref>&#x000a0;</p>
        <p><bold>Leukoplakia:</bold>&#x000a0;This condition is typically associated with long-term irritation and chronic inflammation, most often in patients with diabetes.<xref ref-type="bibr" rid="article-26896.r77">[77]</xref>&#x000a0;Leukoplakia is a rare disorder that appears as whitish, scaly plaques, frequently involving the urethral meatus. Dysplastic histological changes are found in 10% to 20% of these lesions, suggesting a malignant potential.<xref ref-type="bibr" rid="article-26896.r77">[77]</xref>&#x000a0;Squamous cell carcinoma is often found adjacent to these dermatoses.<xref ref-type="bibr" rid="article-26896.r84">[84]</xref><xref ref-type="bibr" rid="article-26896.r85">[85]</xref>&#x000a0;</p>
        <p><bold>Lichen sclerosus:</bold>&#x000a0;This condition, also known as balanitis xerotica obliterans, arises from chronic infection, trauma, or inflammation.<xref ref-type="bibr" rid="article-26896.r86">[86]</xref><xref ref-type="bibr" rid="article-26896.r87">[87]</xref>&#x000a0;Lichen sclerosus presents with flat white patches on the glans and prepuce.<xref ref-type="bibr" rid="article-26896.r86">[86]</xref><xref ref-type="bibr" rid="article-26896.r87">[87]</xref>&#x000a0;This condition is usually asymptomatic, but if symptomatic, lichen sclerosus may present with burning, painful erections, and pruritis.<xref ref-type="bibr" rid="article-26896.r86">[86]</xref><xref ref-type="bibr" rid="article-26896.r87">[87]</xref>&#x000a0;Two percent to&#x000a0;9% of men with this condition may eventually develop penile cancer.<xref ref-type="bibr" rid="article-26896.r88">[88]</xref><xref ref-type="bibr" rid="article-26896.r89">[89]</xref>&#x000a0;</p>
        <p>Lichen sclerosus is the most common penile premalignant lesion not associated with HPV.<xref ref-type="bibr" rid="article-26896.r77">[77]</xref>&#x000a0;Only symptomatic lichen sclerosus requires treatment with topical steroids.<xref ref-type="bibr" rid="article-26896.r86">[86]</xref>&#x000a0;Surgical excision is generally not recommended, except for circumcision, as the recurrence rate is high. Long-term yearly follow-up&#x000a0;is required&#x000a0;due to the risk of malignancy.<xref ref-type="bibr" rid="article-26896.r87">[87]</xref><xref ref-type="bibr" rid="article-26896.r90">[90]</xref>&#x000a0;See StatPearls companion references,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/18121">Balanitis Xerotica Obliterans</ext-link>&#x000a0;and&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/24256">Lichen Sclerosu</ext-link>s, for more information.<xref ref-type="bibr" rid="article-26896.r86">[86]</xref><xref ref-type="bibr" rid="article-26896.r87">[87]</xref></p>
        <p><bold>Pseudoepitheliomatous keratotic and micaceous balanitis:</bold>&#x000a0;This is a&#x000a0;very rare lesion of unknown etiology that&#x000a0;is characterized&#x000a0;by solitary, thick, warty, laminated, hyperkeratotic, whitish-yellowish plaques or scales located on the glans.<xref ref-type="bibr" rid="article-26896.r91">[91]</xref><xref ref-type="bibr" rid="article-26896.r92">[92]</xref><xref ref-type="bibr" rid="article-26896.r93">[93]</xref>&#x000a0;The lesion may demonstrate fissures, irritation, or maceration but is usually asymptomatic and typically found in men who&#x000a0;were circumcised&#x000a0;at an older age.<xref ref-type="bibr" rid="article-26896.r94">[94]</xref>&#x000a0;Progression to verrucous carcinoma, which develops as a nodular exophytic lesion inside the previously identified plaque, has been reported.<xref ref-type="bibr" rid="article-26896.r95">[95]</xref><xref ref-type="bibr" rid="article-26896.r96">[96]</xref><xref ref-type="bibr" rid="article-26896.r97">[97]</xref>&#x000a0;A definitive diagnosis generally requires a biopsy.<xref ref-type="bibr" rid="article-26896.r91">[91]</xref>&#x000a0;</p>
        <p>Early stages can be treated with topical 5-fluorouracil.<xref ref-type="bibr" rid="article-26896.r94">[94]</xref><xref ref-type="bibr" rid="article-26896.r98">[98]</xref>&#x000a0;Other treatments include topical podophyllotoxin, corticosteroids, cryotherapy, radiation therapy, and surgical excision.<xref ref-type="bibr" rid="article-26896.r94">[94]</xref>&#x000a0;The condition tends to be chronic and recurrent despite treatment.<xref ref-type="bibr" rid="article-26896.r94">[94]</xref></p>
        <p>
<bold>Penile Squamous Cell Carcinoma</bold>
</p>
        <p>Penile cancer treatment typically involves a combination of surgery, radiation, and chemotherapy. These approaches aim to remove the cancerous tissue while preserving as much function and appearance as possible.</p>
        <p>
<bold>Managing the primary lesion&#x000a0;</bold>
</p>
        <p>Low-risk tumors can&#x000a0;be managed&#x000a0;with organ- and glans-sparing procedures. Tumors with a low risk of recurrence (Tis involving shaft skin and glans penis, Ta involving glans only, T1a and T1b lesions involving the shaft skin and glans alone) are appropriate for organ- and glans-sparing procedures.&#x000a0;These procedures include topical treatments (5-fluorouracil or imiquimod cream for Tis), radiation therapy, Mohs surgery, laser ablation, and total glans resurfacing.<xref ref-type="bibr" rid="article-26896.r99">[99]</xref><xref ref-type="bibr" rid="article-26896.r100">[100]</xref><xref ref-type="bibr" rid="article-26896.r101">[101]</xref>&#x000a0;</p>
        <p>In general, penile-sparing techniques have a higher local recurrence rate than partial penectomy surgery. Still, they are far less invasive or disfiguring and have a comparable cancer-specific survival rate.&#x000a0;If a patient has stage T1 grade 1 or 2 lesions, it&#x000a0;is recommended&#x000a0;to consider them for penile-preserving techniques, but the patient must be reliable regarding compliance with close follow-up.</p>
        <p>
<bold>Topical therapy and managing penile intraepithelial neoplasia</bold>
</p>
        <p>In premalignant lesions such as penile intraepithelial neoplasia, topical therapy (5-fluorouracil, imiquimod 5%)&#x000a0;is reasonably successful, with a complete response rate of 57% to 73%, but is associated with a high risk of recurrence at 48%.<xref ref-type="bibr" rid="article-26896.r102">[102]</xref><xref ref-type="bibr" rid="article-26896.r103">[103]</xref><xref ref-type="bibr" rid="article-26896.r104">[104]</xref>&#x000a0;The application of a gauze impregnated with 5% acetic acid to the penis for 3 to 5 minutes can help identify premalignant HPV-affected areas that require therapy as they will turn white.<xref ref-type="bibr" rid="article-26896.r105">[105]</xref><xref ref-type="bibr" rid="article-26896.r106">[106]</xref>&#x000a0;&#x000a0;While topical therapy may&#x000a0;be used, alternative surgical treatments, such as Mohs surgery, glans resurfacing, laser ablation, photodynamic therapy, cryotherapy, and surgical excision, are generally preferred (75% to 85%) for&#x000a0;PIN&#x000a0;lesions.<xref ref-type="bibr" rid="article-26896.r107">[107]</xref><xref ref-type="bibr" rid="article-26896.r108">[108]</xref>&#x000a0;A surgical margin of just a few millimeters is considered sufficient.<xref ref-type="bibr" rid="article-26896.r99">[99]</xref><xref ref-type="bibr" rid="article-26896.r108">[108]</xref><xref ref-type="bibr" rid="article-26896.r109">[109]</xref>&#x000a0;Recurrence of penile intraepithelial neoplasia after surgical therapy is about 15% to 20%.<xref ref-type="bibr" rid="article-26896.r110">[110]</xref></p>
        <p>
<bold>Radiation therapy</bold>
</p>
        <p>Radiation therapy can be effective in low-risk, low-stage penile cancers. Interstitial brachytherapy appears to be superior to external beam.<xref ref-type="bibr" rid="article-26896.r111">[111]</xref>&#x000a0;The estimated 5-year control rate with brachytherapy has been reported as 82%, with an overall 5-year survival of 79%.<xref ref-type="bibr" rid="article-26896.r112">[112]</xref>&#x000a0;However, the treatment of penile cancer requires large radiation doses, which results in a relatively high rate of complications such as urethral strictures, secondary infections, urethral mucositis, localized edema, pain,&#x000a0;urethrocutaneous&#x000a0;fistulas, meatal stenosis, and superficial tissue necrosis.<xref ref-type="bibr" rid="article-26896.r113">[113]</xref><xref ref-type="bibr" rid="article-26896.r114">[114]</xref><xref ref-type="bibr" rid="article-26896.r115">[115]</xref><xref ref-type="bibr" rid="article-26896.r116">[116]</xref>&#x000a0;Circumcision is recommended before penile radiation to prevent phimosis induced by the therapy.</p>
        <p>
<bold>Mohs surgery</bold>
</p>
        <p>Mohs surgery&#x000a0;is a microscopic surgical technique&#x000a0;by which horizontal, circumferential tissue slices are taken laterally around and deep to the excised skin lesion. These slices&#x000a0;are microscopically examined&#x000a0;using a frozen section until all margins are negative. The use of horizontal slicing ensures&#x000a0;all&#x000a0;of the skin margins are clear. The advantage of this technique is maximal tissue conservation, with results comparable or even superior to other penile conservation therapies.<xref ref-type="bibr" rid="article-26896.r117">[117]</xref>&#x000a0;Mohs surgery is an alternative to wide primary excision of the cancer.&#x000a0;A local recurrence can&#x000a0;be easily treated&#x000a0;with a repeat Mohs microsurgery. This treatment is appropriate for&#x000a0;small&#x000a0;lesions on the proximal shaft (to avoid a total penectomy in low-risk malignancies), PIN (carcinoma-in-situ lesions), and stages Ta, Tis, and T1 penile cancer, with an overall reported local recurrence rate as low as 2%&#x000a0;(success rates decline with higher stage malignancies).<xref ref-type="bibr" rid="article-26896.r118">[118]</xref><xref ref-type="bibr" rid="article-26896.r119">[119]</xref><xref ref-type="bibr" rid="article-26896.r120">[120]</xref><xref ref-type="bibr" rid="article-26896.r121">[121]</xref><xref ref-type="bibr" rid="article-26896.r122">[122]</xref></p>
        <p>
<bold>Laser ablation</bold>
</p>
        <p>Laser ablation typically utilizes a carbon dioxide, potassium titanyl phosphate, or Nd:YAG&#x000a0;laser.<xref ref-type="bibr" rid="article-26896.r123">[123]</xref>&#x000a0;The procedure&#x000a0;is most useful for carcinoma-in-situ lesions of the penis. Using 5% acetic acid will help visualize areas that require treatment and is necessary for best results.<xref ref-type="bibr" rid="article-26896.r105">[105]</xref><xref ref-type="bibr" rid="article-26896.r124">[124]</xref>&#x000a0;Local recurrences and complications&#x000a0;are&#x000a0;somewhat higher with laser ablation than with partial penectomy surgery, but&#x000a0;1 study showed that&#x000a0;control&#x000a0;was still achieved&#x000a0;in over 90% of patients.<xref ref-type="bibr" rid="article-26896.r117">[117]</xref><xref ref-type="bibr" rid="article-26896.r125">[125]</xref><xref ref-type="bibr" rid="article-26896.r126">[126]</xref>&#x000a0;The resumption of sexual activity can be very rapid, and the technique enjoys high patient satisfaction scores.<xref ref-type="bibr" rid="article-26896.r127">[127]</xref>&#x000a0;Carbon dioxide laser surgery with methyl aminolevulinate-photodynamic therapy has also been used successfully in early-stage lesions.<xref ref-type="bibr" rid="article-26896.r128">[128]</xref></p>
        <p>
<bold>Total glans resurfacing</bold>
</p>
        <p>Total glans resurfacing requires the surgical removal of the skin and lamina propria to the corpus spongiosum, after which a skin graft&#x000a0;is used&#x000a0;to cover the defect.<xref ref-type="bibr" rid="article-26896.r129">[129]</xref><xref ref-type="bibr" rid="article-26896.r130">[130]</xref>&#x000a0;This procedure works quite well for&#x000a0;PIN (formerly squamous cell carcinoma-in-situ, erythroplasia of Queyrat) with low recurrence rates reported, although&#x000a0;there is a relatively high need for surgical revision at over 25%.<xref ref-type="bibr" rid="article-26896.r117">[117]</xref><xref ref-type="bibr" rid="article-26896.r131">[131]</xref><xref ref-type="bibr" rid="article-26896.r132">[132]</xref>&#x000a0;Frozen sections of the urethral stump and the cavernosa should&#x000a0;be sent and used&#x000a0;to ensure&#x000a0;negative surgical margins.&#x000a0;Most published reports are&#x000a0;very small&#x000a0;series from single institutions, and long-term results are unavailable.<xref ref-type="bibr" rid="article-26896.r133">[133]</xref></p>
        <p><bold>Wide local surgical excision</bold>&#x000a0;</p>
        <p>Wide local surgical excision&#x000a0;of the primary tumor (eg, circumcision where appropriate) remains the gold standard for rapid definitive treatment of penile cancer.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r117">[117]</xref>&#x000a0;Split-thickness or full-thickness skin grafts may be needed to accomplish this. If the margins are not clear, a repeat resection may be needed.&#x000a0;Circumcision alone may be appropriate for lesions located exclusively on the foreskin.</p>
        <p>
<bold>Total or partial penectomy</bold>
</p>
        <p>Total or partial penectomy&#x000a0;is recommended&#x000a0;for high-grade primary penile cancers or evidence of corpora cavernosal invasion that cannot&#x000a0;be safely managed&#x000a0;with wide local surgical excision or other less invasive techniques.&#x000a0;Patients with stage T1 grade 3 or 4 lesions or T2 lesions or greater typically require more extensive surgical intervention with a partial or total penectomy.&#x000a0;A partial penectomy can only&#x000a0;be performed&#x000a0;when the remaining penile stump is sufficiently functional with negative margins. If this is not possible, a total penectomy will be required.</p>
        <p>Frozen sections during surgery&#x000a0;are recommended&#x000a0;to ensure the surgical margins are negative.<xref ref-type="bibr" rid="article-26896.r134">[134]</xref>&#x000a0;Traditionally, a 2 cm tumor-free margin has been recommended, but a&#x000a0;5 mm tumor-free margin is now the standard as it has been proven equally safe and effective.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref><xref ref-type="bibr" rid="article-26896.r135">[135]</xref>&#x000a0;If possible,&#x000a0;2 cm to&#x000a0;3 cm of penile length should be left to allow the patient to have some degree of sexual function and to void in the standing position.&#x000a0;A total penectomy removes all of the penis distal to the pubic bone.<xref ref-type="bibr" rid="article-26896.r136">[136]</xref>&#x000a0;The urethral stump&#x000a0;is diverted&#x000a0;into the perineum with a perineal urethrostomy, so the patient must permanently void in the&#x000a0;seated position.<xref ref-type="bibr" rid="article-26896.r136">[136]</xref></p>
        <p>
<bold>Managing Lymph Nodes&#x000a0;</bold>
</p>
        <p>Managing regional lymph nodes in penile cancer is quite&#x000a0;important, as the presence and extent of regional inguinal lymph node metastases is the single most important prognostic indicator in determining the long-term survival of men with squamous cell carcinoma of the penis. Up&#x000a0;to 25% of patients with nonpalpable lymph nodes harbor micrometastases.&#x000a0;Several factors help predict the risk of microscopic inguinal lymph nodal metastases. Tis, Ta, and T1 tumors have a risk of metastases from 4% to 14%. T2 and greater tumors are associated with a significantly higher risk of metastases to the inguinal lymph nodes.</p>
        <p>Metastatic potential is also associated with higher histological tumor grade; the higher the grade, the greater the risk for metastases. Lymphovascular or perineural invasion is also associated with a greater risk of metastases. Patients&#x000a0;are stratified&#x000a0;into groups of low-risk or high-risk for nodal involvement.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Low-risk:</bold>&#x000a0;Tis, Ta, and T1a tumors; no lymphovascular invasion or perineural invasion; histological grades 1 and 2</p>
          </list-item>
          <list-item>
            <p><bold>High-risk:</bold>&#x000a0;Histological grade 3 tumors, lymphovascular or perineural invasion present (T1b), and stage T2 or higher&#x000a0;<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r63">[63]</xref><xref ref-type="bibr" rid="article-26896.r137">[137]</xref></p>
          </list-item>
        </list>
        <p><bold>Dynamic sentinel node biopsies</bold>&#x000a0;</p>
        <p>Dynamic sentinel node biopsies&#x000a0;are becoming more popular for patients with high-risk&#x000a0;disease.&#x000a0;The increase in procedures&#x000a0;is based&#x000a0;on the finding that identifiable and predictable sentinel lymph nodes are typically the first to be involved with any metastatic spread of disease from specific regions, such as the penis. This technique has far less morbidity than inguinal lymph node dissections. Usually, the tumor&#x000a0;is injected&#x000a0;with a radioactive tracer (lymphoscintigraphy) and a vital blue dye for visual lymph node staining.&#x000a0;</p>
        <p>Lymphoscintigraphy&#x000a0;is performed&#x000a0;with a technetium-99m-labeled&#x000a0;nanocolloid and patent blue dye stain (isosulfan&#x000a0;blue) to visually identify the sentinel lymph nodes in the inguinal region&#x000a0;and allow for excisional biopsy of selected nodes for pathological evaluation. This process is followed by examining the lymphatic drainage system using nuclear medicine detection and direct visual examinations.<xref ref-type="bibr" rid="article-26896.r138">[138]</xref>&#x000a0;</p>
        <p>A meta-analysis of sentinel node biopsies found that the overall sensitivity was about 90%.<xref ref-type="bibr" rid="article-26896.r139">[139]</xref>&#x000a0;Better results&#x000a0;were reported&#x000a0;in high-volume tertiary care centers with substantial experience in this procedure.<xref ref-type="bibr" rid="article-26896.r140">[140]</xref>&#x000a0;Palpable nodes should be biopsied, preferably with ultrasound-guided fine needle aspiration.<xref ref-type="bibr" rid="article-26896.r64">[64]</xref></p>
        <p>
<bold>Inguinal lymph node dissections</bold>
</p>
        <p>Inguinal lymph node dissections&#x000a0;should&#x000a0;be performed&#x000a0;on patients with proven metastases or high-risk disease; this is a highly morbid procedure, especially the superficial dissection.&#x000a0;The&#x000a0;boundaries of the&#x000a0;standard, full template are the inguinal ligament superiorly, the fossa&#x000a0;ovalis&#x000a0;inferiorly, the medial border of the sartorius muscle laterally, and the lateral edge of the adductor&#x000a0;longus&#x000a0;muscle medially.&#x000a0;The fascia lata separates the superficial and deep inguinal lymph nodes.</p>
        <p>The superficial nodes&#x000a0;are divided&#x000a0;into&#x000a0;5&#x000a0;zones. The deep inguinal lymph nodes are deep to the fascial lata and medial to the femoral vein in the femoral triangle. The node of Cloquet is the most cephalad node in the deep inguinal region. During radical inguinal lymph node dissection, the saphenous vein&#x000a0;is ligated&#x000a0;from where it arises from the femoral vein and again where it passes through the fossa&#x000a0;ovalis, after which the vein segment&#x000a0;is removed. A sartorius muscle flap&#x000a0;is used&#x000a0;to cover&#x000a0;the femoral vessels after the dissection.&#x000a0;</p>
        <p>Laparoscopic and robotic techniques have also&#x000a0;been described, which are comparable to open lymph node dissections but offer considerably less morbidity.<xref ref-type="bibr" rid="article-26896.r141">[141]</xref><xref ref-type="bibr" rid="article-26896.r142">[142]</xref><xref ref-type="bibr" rid="article-26896.r143">[143]</xref><xref ref-type="bibr" rid="article-26896.r144">[144]</xref>&#x000a0;These techniques typically offer fewer skin complications, less lymphedema, higher numbers of lymph nodes, and less overall morbidity compared to open procedures.<xref ref-type="bibr" rid="article-26896.r145">[145]</xref>&#x000a0;Further studies are needed to determine long-term outcomes and disease-specific survival with these new techniques.<xref ref-type="bibr" rid="article-26896.r145">[145]</xref></p>
        <p>A modified inguinal lymph node dissection technique has also been described and can&#x000a0;be recommended&#x000a0;for patients with a&#x000a0;normal&#x000a0;inguinal exam but high-risk penile cancers. This technique uses a smaller skin incision and narrows the field of inguinal dissection by excluding the area lateral to the femoral artery and caudal to the fossa&#x000a0;ovalis. This technique also preserves the saphenous vein and eliminates muscle flap transposition.<xref ref-type="bibr" rid="article-26896.r146">[146]</xref><xref ref-type="bibr" rid="article-26896.r147">[147]</xref>&#x000a0;This template allows for&#x000a0;good&#x000a0;oncologic control as it targets the most common site for metastases while decreasing morbidity by narrowing the incision and decreasing the disruption to lymphatic drainage. Frozen sections should&#x000a0;be obtained&#x000a0;when using this template. If nodal involvement&#x000a0;is identified, the procedure should&#x000a0;be converted&#x000a0;to a&#x000a0;full&#x000a0;standard lymphadenectomy.<xref ref-type="bibr" rid="article-26896.r146">[146]</xref><xref ref-type="bibr" rid="article-26896.r147">[147]</xref></p>
        <p>As bilateral inguinal lymphatic drainage is&#x000a0;common, a staging lymph node procedure on the contralateral side should also be performed (dynamic sentinel node biopsy or an inguinal lymph node dissection).<xref ref-type="bibr" rid="article-26896.r148">[148]</xref>&#x000a0;Ipsilateral pelvic lymph node dissections&#x000a0;should&#x000a0;be considered&#x000a0;in men with&#x000a0;2&#x000a0;or more inguinal ipsilateral nodal metastases, metastasis to the node of Cloquet, tumor extension through the capsule of the inguinal lymph nodes, or the presence of high-grade tumor in involved nodes. The pelvic nodes will not become involved unless the ipsilateral inguinal lymphatics have already been affected.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref>&#x000a0;The European Association of Urology (EAU) and the National Comprehensive Cancer Network (NCCN) have prepared treatment guidelines for the management of penile carcinoma (NCCN Guidelines on Penile Cancer Version 1.2023).<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r137">[137]</xref><xref ref-type="bibr" rid="article-26896.r149">[149]</xref></p>
        <p>
<bold>Men with low-risk disease and nonpalpable inguinal lymph nodes</bold>
</p>
        <p>Men with low-risk disease and nonpalpable inguinal lymph nodes have a 0%&#x000a0;to 16% chance of nodal metastases. The EAU and the NCCN recommend offering these men surveillance rather than surgical staging. However, these men must be reliable and comply with follow-up recommendations. If they are unreliable or unwilling to proceed with surveillance, they should undergo bilateral inguinal node staging, either with dynamic sentinel node biopsy or bilateral inguinal lymph node dissections (superficial or modified).</p>
        <p>
<bold>Men with nonpalpable inguinal lymph nodes but high-risk disease</bold>
</p>
        <p>Men with nonpalpable inguinal lymph nodes but high-risk&#x000a0;disease&#x000a0;should undergo a sentinel node biopsy or an inguinal lymph node dissection (superficial or modified). If the nodes are negative, posttreatment surveillance&#x000a0;is recommended. Patients with&#x000a0;1&#x000a0;involved inguinal lymph node and without extranodal extension require complete ipsilateral inguinal lymph node dissection.&#x000a0;If a patient has&#x000a0;2&#x000a0;or more positive nodes or&#x000a0;1&#x000a0;positive node and evidence of extranodal extension, he should undergo a therapeutic ipsilateral inguinal lymph node dissection and a unilateral or bilateral pelvic lymph node dissection.</p>
        <p>
<bold>Men who present with a unilateral, solitary inguinal node</bold>
</p>
        <p>Men who present with a unilateral, solitary inguinal node&#x000a0;that is less than 4 cm should undergo fine needle aspiration (FNA) of the palpable node. A superficial and deep inguinal lymph node dissection should be performed if the FNA is positive.&#x000a0;If the FNA is negative, excisional biopsy, superficial inguinal lymph node dissection, or surveillance is appropriate. If two or more nodes are positive or there is evidence of extranodal extension on inguinal lymph node dissection, it&#x000a0;is recommended&#x000a0;to proceed with a pelvic lymph node dissection. These patients are also candidates for adjuvant chemotherapy and radiation as they are at higher risk for recurrences.</p>
        <p>
<bold>Men with multiple or bilateral palpable inguinal nodes</bold>
</p>
        <p>Men with multiple or bilateral palpable inguinal nodes should undergo an FNA of&#x000a0;1 of the nodes for initial staging examination. If the FNA is negative, the surgeon should perform an excisional biopsy or superficial inguinal lymph node dissection with frozen sections obtained intraoperatively.&#x000a0;Take into account that 30% to 50% of patients with palpable disease will&#x000a0;simply&#x000a0;have inflammatory nodal swelling instead of metastases.&#x000a0;For this reason, it&#x000a0;is preferred&#x000a0;to obtain a tissue biopsy to prove metastases.&#x000a0;It is becoming more common to obtain a dynamic sentinel node biopsy to avoid the morbidity of lymph node dissections. If the patient&#x02019;s biopsy is positive, he should undergo neoadjuvant chemotherapy and then inguinal as well as pelvic lymph node dissections to optimize his survival.</p>
        <p>
<bold>Management of Recurrences</bold>
</p>
        <p>In&#x000a0;a large&#x000a0;study of 314 patients with penile cancer, results showed local recurrences&#x000a0;in 35% of patients at a median period of 10.4 months.<xref ref-type="bibr" rid="article-26896.r150">[150]</xref>&#x000a0;The treatment of choice is surgical removal by wide local excision with negative margins. Disease-specific survival was good when local recurrences were recognized and treated promptly.<xref ref-type="bibr" rid="article-26896.r151">[151]</xref>&#x000a0;A reevaluation of the inguinal and pelvic lymph nodes (dynamic sentinel node biopsy or inguinal lymph node dissection) is recommended, especially if a lymph node dissection&#x000a0;was not previously performed.&#x000a0;</p>
        <p>An inguinal recurrence carries a much more ominous prognosis. In such cases, multimodality treatment&#x000a0;is usually recommended&#x000a0;with chemotherapy plus surgery or chemoradiation.<xref ref-type="bibr" rid="article-26896.r150">[150]</xref><xref ref-type="bibr" rid="article-26896.r151">[151]</xref><xref ref-type="bibr" rid="article-26896.r152">[152]</xref>&#x000a0;Clinical trials should be considered, and palliative care should&#x000a0;be offered.&#x000a0;If the recurrence is not surgically resectable, the patient has fixed groin masses, or has&#x000a0;a large&#x000a0;tumor burden, the available treatments are limited to palliative therapies and clinical trials. Chemotherapy can&#x000a0;be considered, if not previously administered, followed by surgery and palliative radiation therapy.<xref ref-type="bibr" rid="article-26896.r153">[153]</xref>&#x000a0;Palliative chemotherapy is another option for these individuals.</p>
        <p>
<bold>Clinical Trials</bold>
</p>
        <p>According to the NCCN, patients with penile cancer are best served by enrollment in a clinical trial whenever possible.&#x000a0;</p>
        <p><bold>In the United States,&#x000a0;</bold>information on clinical trials is available from&#x000a0;the National Cancer Institute and other sources at:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cancer.gov/about-cancer/treatment/clinical-trials/disease/penile-cancer/treatment</p>
          </list-item>
          <list-item>
            <p>Cancer.net/cancer-types/penile-cancer/about-clinical-trials</p>
          </list-item>
          <list-item>
            <p>Clinicaltrials.gov</p>
          </list-item>
        </list>
        <p><bold>In the United Kingdom,&#x000a0;</bold>similar information can&#x000a0;be found&#x000a0;at:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cancerresearchuk.org/about-cancer/penile-cancer/research-clinical-trials&#x000a0;</p>
          </list-item>
        </list>
        <p>Enrollment in a clinical trial for this uncommon cancer is strongly encouraged, especially for the more advanced stages.</p>
      </sec>
      <sec id="article-26896.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Besides squamous cell carcinoma, which constitutes over 95% of all penile cancers, other malignancies may also develop. These include basal cell carcinoma, melanoma, sarcoma, metastatic malignancies, and adenosquamous carcinoma.<xref ref-type="bibr" rid="article-26896.r154">[154]</xref><xref ref-type="bibr" rid="article-26896.r155">[155]</xref><xref ref-type="bibr" rid="article-26896.r156">[156]</xref><xref ref-type="bibr" rid="article-26896.r157">[157]</xref><xref ref-type="bibr" rid="article-26896.r158">[158]</xref>&#x000a0;Other lesions include the following:</p>
        <p><bold>Angiokeratomas:</bold>&#x000a0;These are scaly papules that usually form on the glans. They&#x000a0;usually occur as multiple lesions that are smaller than 1 cm each.<xref ref-type="bibr" rid="article-26896.r159">[159]</xref></p>
        <p><bold>Balanitis and&#x000a0;balanoposthitis:</bold>&#x000a0;These&#x000a0;are usually fungal infections of the glans or foreskin.&#x000a0;They are&#x000a0;usually sore, itchy, and odoriferous, with redness and swelling&#x02014;and often result&#x000a0;in dysuria and pus.&#x000a0;The infections typically respond to topical antifungals&#x000a0;(if&#x000a0;they do not, penile carcinoma becomes&#x000a0;more likely, and a biopsy should&#x000a0;be considered).<xref ref-type="bibr" rid="article-26896.r91">[91]</xref><xref ref-type="bibr" rid="article-26896.r160">[160]</xref>&#x000a0;See StatPearls&#x02019; companion references,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/www.statpearls.com/point-of-care/18119">Balanitis</ext-link>&#x000a0;and&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/www.statpearls.com/point-of-care/18122">Balanoposthitis</ext-link>, for more information.</p>
        <p><bold>Condyloma acuminatum, genital warts:</bold>&#x000a0;These are&#x000a0;non-tender&#x000a0;wart-like lesions or papillary frond-like lesions.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="28722914">[119]</ext-link>&#x000a0;Genital warts are&#x000a0;an STI caused by HPV.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="28722914">[119]</ext-link>&#x000a0;Treatment is usually topical medications (podophyllotoxin, imiquimod, sinecatechins as a 15% ointment, or isotretinoin),&#x000a0;but may include surgery, cryotherapy,&#x000a0; laser ablation, or photodynamic therapy.<xref ref-type="bibr" rid="article-26896.r46">[40]</xref>&#x000a0;See StatPearls&#x02019; companion reference,&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.statpearls.com/point-of-care/22202">Genital Warts</ext-link>,&#x000a0;for more information.</p>
        <p><bold>Lichen planus:</bold>&#x000a0;This is an inflammatory skin condition with an immunological etiology, possibly related to hepatitis C and various drug reactions.<xref ref-type="bibr" rid="article-26896.r69">[120]</xref>&#x000a0;The usual appearance is well-circumscribed purple plaques anywhere on the penis.<xref ref-type="bibr" rid="article-26896.r69">[120]</xref>&#x000a0;Mucosal surfaces may demonstrate erosive or annular dermatoses.<xref ref-type="bibr" rid="article-26896.r69">[120]</xref>&#x000a0;Cutaneous lesions tend to resolve spontaneously by 18 months, but mucosal dermatoses will return intermittently.<xref ref-type="bibr" rid="article-26896.r69">[120]</xref>&#x000a0;</p>
        <p>While usually considered benign, premalignant changes may rarely occur.<xref ref-type="bibr" rid="article-26896.r48">[42]</xref><xref ref-type="bibr" rid="article-26896.r69">[120]</xref>&#x000a0;Treatment is initially with high-potency topical steroids.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="22336835">[121]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="32678513">[122]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="18647310">[123]</ext-link>&#x000a0;Topical calcineurin inhibitors may also be beneficial, and cyclosporine can&#x000a0;be used&#x000a0;if the lesion is erosive.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="31265737">[124]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="16332242">[125]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="8245246">[126]</ext-link>&#x000a0;Severe cases may rarely require oral steroids, and circumcision may occasionally be needed.<xref ref-type="bibr" rid="article-26896.r69">[120]</xref><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="27358167">[127]</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="11683298">[128]</ext-link>&#x000a0;</p>
        <p><bold>Papillomas:</bold>&#x000a0;These benign lesions consist of rows of 1 mm to 2 mm white&#x000a0;or yellow papules on the corona of the glans. Treatment is not required.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="32809572">[129]</ext-link></p>
        <p><bold>Psoriasis:</bold>&#x000a0;This condition consists of erythematous plaques that are elevated above the usual skin level and have sharply defined margins. The plaques are almost always associated with similar skin lesions elsewhere.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="28846344">[130]</ext-link></p>
        <p><bold>Syphilis:</bold>&#x000a0;Early syphilis starts as a painless ulcer with possible lymphadenopathy. Unlike penile cancer, these ulcers heal even without treatment,&#x000a0;and serological testing for syphilis will be positive.<xref ref-type="bibr" rid="article-26896.r186">[131]</xref></p>
      </sec>
      <sec id="article-26896.s11" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>Primary penile radiation therapy is appropriate for stage Tis, T1, and T2 lesions that are smaller than 4 cm. This therapy can&#x000a0;be administered&#x000a0;as external beam radiation therapy or interstitial brachytherapy. Radiation has a higher local recurrence rate than partial or total penectomy. High doses of radiation are required to eradicate penile squamous cell carcinoma, and therefore, complications are not uncommon. The 2 most common late&#x000a0;adverse effects of radiation therapy are meatal stenosis and soft-tissue ulceration. Circumcision should be performed before penile radiation therapy to prevent radiation-induced phimosis.<xref ref-type="bibr" rid="article-26896.r114">[114]</xref><xref ref-type="bibr" rid="article-26896.r115">[115]</xref></p>
        <p>HPV is estimated to be a causative factor in at least&#x000a0;40% and up to&#x000a0;80% of penile cancer patients. HPV-positive squamous cell cancers of the head and neck respond well to radiation therapy. Still, there is only limited and anecdotal evidence that this also applies to penile cancer.&#x000a0;Bandini et al reported a retrospective analysis from&#x000a0;a large&#x000a0;international database of 507 patients with penile cancers who underwent inguinal lymph node dissections.<xref ref-type="bibr" rid="article-26896.r161">[161]</xref>&#x000a0;They then reviewed the effect of radiation therapy on overall survival. They found HPV-positive penile cancer patients had a significantly better response to radiation and improved overall survival than their HPV-negative counterparts.<xref ref-type="bibr" rid="article-26896.r28">[28]</xref><xref ref-type="bibr" rid="article-26896.r161">[161]</xref></p>
        <p>Adjuvant radiation therapy to the inguinal or pelvic regions has not&#x000a0;been thoroughly evaluated. Guidelines currently do not recommend it as prophylaxis for high-risk patients, and it is less effective therapeutically than a lymph node dissection for clinically involved nodes. However, it may be&#x000a0;useful for&#x000a0;palliation in patients with inoperable nodes and selected cases with locally advanced disease.&#x000a0;</p>
        <p>Some experts have suggested adjuvant radiation alone or with chemotherapy, although&#x000a0;this remains controversial.<xref ref-type="bibr" rid="article-26896.r162">[162]</xref><xref ref-type="bibr" rid="article-26896.r163">[163]</xref>&#x000a0;This treatment is most appropriate for patients with extranodal extension and bilateral nodal disease and high-risk patients who are not candidates for adjuvant chemotherapy.&#x000a0;When combined chemoradiation&#x000a0;is chosen, the usual chemotherapeutic agents include cisplatin alone or a combination of fluorouracil and mitomycin.<xref ref-type="bibr" rid="article-26896.r163">[163]</xref>&#x000a0;Some good responses have&#x000a0;been reported&#x000a0;with chemoradiation.<xref ref-type="bibr" rid="article-26896.r152">[152]</xref>&#x000a0;Enrollment in a clinical trial is strongly recommended.</p>
      </sec>
      <sec id="article-26896.s12" sec-type="Medical Oncology">
        <title>Medical Oncology</title>
        <p>Neoadjuvant chemotherapy should&#x000a0;be considered&#x000a0;for patients with an unresectable primary tumor, bulky lymphadenopathy, or bilateral inguinal adenopathy. These patients have a low probability of being cured by surgery alone. The paclitaxel, ifosfamide, and cisplatin regimen is the standard chemotherapy combination used.&#x000a0;This&#x000a0;is given at&#x000a0;3- to 4-week intervals for&#x000a0;4&#x000a0;cycles. Response rates are reported as 65%, with a substantially higher 5-year survival (50%&#x000a0;vs&#x000a0;8%) in responders compared with those who progressed on chemotherapy.<xref ref-type="bibr" rid="article-26896.r164">[164]</xref><xref ref-type="bibr" rid="article-26896.r165">[165]</xref>&#x000a0;</p>
        <p>Patients with&#x000a0;a good&#x000a0;clinical response to chemotherapy and stable disease should have a surgical resection.&#x000a0;Alternative regimens include cisplatin plus fluorouracil and paclitaxel plus carboplatin (usually for patients unable to take cisplatin).<xref ref-type="bibr" rid="article-26896.r166">[166]</xref><xref ref-type="bibr" rid="article-26896.r167">[167]</xref>&#x000a0;Patients with significant disease who progress on initial chemotherapy generally have&#x000a0;a very poor&#x000a0;prognosis as their median survival is&#x000a0;less than&#x000a0;6&#x000a0;months.<xref ref-type="bibr" rid="article-26896.r168">[168]</xref>&#x000a0;These patients should be offered palliative care and enrolled in a clinical trial.&#x000a0;</p>
        <p>Investigational treatments include epidermal growth factor receptor modifiers (cetuximab, panitumumab) and immune checkpoint inhibitors.&#x000a0;Anecdotally, pembrolizumab&#x000a0;(a selective monoclonal antibody that inhibits the programmed cell death-1 receptor)&#x000a0;has shown&#x000a0;promising activity in a few selected cases unresponsive to other therapies.<xref ref-type="bibr" rid="article-26896.r169">[169]</xref>&#x000a0;Using agents that target deoxyribonucleic acid mismatch repair deficiencies or microsatellite instability also appears promising. All of these agents have shown beneficial responses.<xref ref-type="bibr" rid="article-26896.r170">[170]</xref><xref ref-type="bibr" rid="article-26896.r171">[171]</xref><xref ref-type="bibr" rid="article-26896.r172">[172]</xref>&#x000a0;</p>
        <p>Other experimental treatments&#x000a0;investigated&#x000a0;include targeted therapies, HPV-directed modalities, and adoptive T-cell therapies.<xref ref-type="bibr" rid="article-26896.r173">[173]</xref>&#x000a0;The combination of new immune-based treatments together with existing and other investigational systemic therapies may ultimately offer the most benefit to patients with advanced penile cancer who currently face a dismal prognosis.<xref ref-type="bibr" rid="article-26896.r173">[173]</xref></p>
        <p>There is little evidence for the role of adjuvant therapy in men with penile carcinoma.&#x000a0;However, it has&#x000a0;been suggested&#x000a0;in patients with bilateral nodal involvement, extranodal extension,&#x000a0;more than&#x000a0;3&#x000a0;positive&#x000a0;nodes,&#x000a0;or positive pelvic lymph nodes.&#x000a0;A positive response&#x000a0;was recently reported&#x000a0;in a patient whose metastatic penile cancer progressed after standard cisplatin-based chemotherapy and radiation. He had&#x000a0;significant&#x000a0;expression of programmed cell death-ligand 1 and&#x000a0;<italic toggle="yes">CDKN2A</italic>&#x000a0;mutations; he responded particularly well to&#x000a0;cemiplimab&#x000a0;with a durable, complete response.<xref ref-type="bibr" rid="article-26896.r174">[174]</xref></p>
      </sec>
      <sec id="article-26896.s13" sec-type="Staging">
        <title>Staging</title>
        <p>The TNM staging system developed by the American Joint Committee on Cancer is generally used&#x000a0;for staging carcinoma of the penis. Currently, it is&#x000a0;in&#x000a0;its 8th edition and is used to define prognostic stage groups and to develop an appropriate treatment plan.<xref ref-type="bibr" rid="article-26896.r175">[175]</xref></p>
        <p>
<bold>Primary Tumor (T)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Tx:</bold>&#x000a0;Primary tumor cannot&#x000a0;be assessed</p>
          </list-item>
          <list-item>
            <p><bold>T0:</bold>&#x000a0;No evidence of the primary tumor</p>
          </list-item>
          <list-item>
            <p><bold>Tis:</bold>&#x000a0;Carcinoma in situ</p>
          </list-item>
          <list-item>
            <p><bold>Ta:</bold>&#x000a0;Noninvasive localized squamous cell carcinoma</p>
          </list-item>
          <list-item>
            <p><bold>T1:</bold>&#x000a0;Invasion of subepithelial connective tissue
<list list-type="bullet"><list-item><p><bold>Glans:</bold>&#x000a0;Tumor invades the lamina propria</p></list-item><list-item><p><bold>Foreskin:</bold>&#x000a0;Tumor invades the dermis, lamina propria, or dartos fascia</p></list-item><list-item><p><bold>Shaft:</bold>&#x000a0;Tumor invades the connective tissue between the epidermis and corpora, regardless of location</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>T1a:</bold>&#x000a0;Tumor is without lymphovascular invasion or perineural invasion and is not&#x000a0;high-grade</p>
          </list-item>
          <list-item>
            <p><bold>T1b:</bold>&#x000a0;Tumor exhibits lymphovascular invasion or perineural invasion&#x000a0;or is&#x000a0;high-grade</p>
          </list-item>
          <list-item>
            <p><bold>T2:</bold>&#x000a0;Tumor invades into corpus spongiosum (either glans or ventral shaft) with or without urethral invasion</p>
          </list-item>
          <list-item>
            <p><bold>T3:</bold>&#x000a0;Tumor invades into corpora cavernosum (including tunica albuginea) with or without urethral invasion</p>
          </list-item>
          <list-item>
            <p><bold>T4:</bold>&#x000a0;Tumor invades into adjacent structures (scrotum, prostate, pubic bone)</p>
          </list-item>
        </list>
        <p>
<bold>Regional Lymph Nodes (N)</bold>
</p>
        <p>
<bold>Clinical N (cN)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>cNX:</bold>&#x000a0;Regional lymph nodes cannot&#x000a0;be assessed</p>
          </list-item>
          <list-item>
            <p><bold>cN0:</bold>&#x000a0;No palpable or visibly enlarged inguinal lymph nodes</p>
          </list-item>
          <list-item>
            <p><bold>cN1:</bold>&#x000a0;Palpable mobile unilateral inguinal lymph node</p>
          </list-item>
          <list-item>
            <p><bold>cN2:</bold>&#x000a0;Palpable mobile&#x000a0;2&#x000a0;or more unilateral or bilateral inguinal lymph nodes</p>
          </list-item>
          <list-item>
            <p><bold>cN3:</bold>&#x000a0;Palpable fixed inguinal nodal mass or pelvic lymphadenopathy unilateral or bilateral</p>
          </list-item>
        </list>
        <p>
<bold>Pathological N (pN)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>pNX:</bold>&#x000a0;Lymph node metastasis cannot&#x000a0;be established</p>
          </list-item>
          <list-item>
            <p><bold>pN0:</bold>&#x000a0;No lymph node metastasis</p>
          </list-item>
          <list-item>
            <p><bold>pN1:</bold>&#x000a0;Up to 2 unilateral inguinal metastases, no extranodal extension</p>
          </list-item>
          <list-item>
            <p><bold>pN2:</bold>&#x000a0;3 or more unilateral inguinal or bilateral metastases</p>
          </list-item>
          <list-item>
            <p><bold>pN3:</bold>&#x000a0;Extranodal extension of inguinal or pelvic lymph node metastases</p>
          </list-item>
        </list>
        <p>
<bold>Distant Metastasis (M)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>M0:</bold>&#x000a0;No distant metastasis</p>
          </list-item>
          <list-item>
            <p><bold>M1:</bold>&#x000a0;Distant metastasis</p>
          </list-item>
        </list>
        <p>
<bold>Anatomic Stage&#x000a0;and Prognostic Groups</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Stage 0:&#x000a0;</bold>TiS or Ta, N0, M0</p>
          </list-item>
          <list-item>
            <p><bold>Stage I:</bold>&#x000a0;T1a, N0, M0</p>
          </list-item>
          <list-item>
            <p><bold>Stage IIA:</bold>&#x000a0;T1b, N0, M0; or T2, N0, M0</p>
          </list-item>
          <list-item>
            <p><bold>Stage IIB:</bold>&#x000a0;T3, N0, M0</p>
          </list-item>
          <list-item>
            <p><bold>Stage&#x000a0;IIIA:</bold>&#x000a0;T1-3, N1, M0</p>
          </list-item>
          <list-item>
            <p><bold>Stage&#x000a0;IIIB:</bold>&#x000a0;T1-3, N2, M0</p>
          </list-item>
          <list-item>
            <p><bold>Stage IV:&#x000a0;</bold>T4, any N, M0;&#x000a0;or any T, N3, M0; or any T, Any N, M1</p>
          </list-item>
        </list>
        <p>
<bold>Staging Approach and Treatment Summary</bold>
</p>
        <p>The clinical exam is essential for the initial evaluation of a patient with suspected penile carcinoma. A thorough examination of the inguinal lymph nodes is necessary, with attempts to evaluate and assess for the palpability of nodes, the number of inguinal masses, if the masses are unilateral or bilateral in location, size, mobility, relationship to other structures, and edema of the patient&#x02019;s penis, scrotum or legs. Fully describing the diameter of any nodes or inguinal masses, laterality (unilateral or bilateral), precise location, number of nodes identified in each region, and whether these nodes are mobile or fixed is essential.&#x000a0;The European Association of Urology and the NCCN have created the following guidelines to determine the treatment based on the initial clinical staging.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref><xref ref-type="bibr" rid="article-26896.r137">[137]</xref></p>
        <p>
<bold>Men with a clinically negative inguinal exam</bold>
</p>
        <p>The extent of staging&#x000a0;is based&#x000a0;on the risk of occult nodal metastases.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Low-risk disease (PTis, Ta, or T1a, histologic grade 1):</bold>&#x000a0;Patients should undergo surveillance rather than a pathological nodal assessment by DSNB or superficial inguinal lymph node dissection.</p>
          </list-item>
          <list-item>
            <p><bold>Intermediate-risk disease (pT1a, histologic grade 2):</bold>&#x000a0;Patients should undergo a namic sentinel node biopsy (DSNB) or superficial inguinal lymph node dissection.</p>
          </list-item>
          <list-item>
            <p><bold>High-risk disease (&#x0003e;pT1b):</bold>&#x000a0;Patients&#x000a0;should undergo an inguinal lymph node dissection (superficial or modified) or a DSNB, depending on surgical expertise.&#x000a0;CT, MRI, or inguinal ultrasound imaging may be&#x000a0;useful&#x000a0;in preoperative planning.</p>
          </list-item>
        </list>
        <p>
<bold>Men with a suspicious or positive inguinal exam</bold>
</p>
        <p>Obtaining an FNA is recommended for pathologic assessment.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Low-risk disease (Tis, Ta, T1a):</bold>&#x000a0;Patients with clinically suspicious adenopathy but a negative FNA should undergo an excisional biopsy for a definitive pathological evaluation.</p>
          </list-item>
          <list-item>
            <p><bold>High-risk disease (&#x0003e;T1b):</bold>&#x000a0;Patients with clinically suspicious adenopathy but a negative FNA should proceed with a superficial or modified inguinal lymph node dissection.</p>
          </list-item>
        </list>
        <p>Patients with penile cancer presenting with bulky, fixed inguinal or pelvic lymph nodes have relatively low survival rates when treated with surgery alone and are candidates for a multimodal treatment approach or a clinical trial.</p>
      </sec>
      <sec id="article-26896.s14" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The presence and extent of regional inguinal lymph nodal metastases, as well as the tumor grade, have been identified as the most important prognostic indicators in determining long-term survival in men with invasive penile squamous cell carcinoma.<xref ref-type="bibr" rid="article-26896.r176">[176]</xref><xref ref-type="bibr" rid="article-26896.r177">[177]</xref>&#x000a0;This prognosis varies depending on the number of positive lymph nodes, the presence of unilateral or bilateral inguinal extension, and pelvic lymph node involvement.<xref ref-type="bibr" rid="article-26896.r176">[176]</xref><xref ref-type="bibr" rid="article-26896.r177">[177]</xref>&#x000a0; For this reason, evaluation of the groin and pelvis is essential in the metastatic workup of a patient with penile cancer.</p>
        <p>The clinical exam is crucial for assessing palpability, the number of inguinal masses, unilateral or bilateral localization, and the relative mobility or fixation of any inguinal masses.&#x000a0;The American Cancer Society has estimated the overall 5-year survival of patients with penile cancer in the United States at 65%, but patients with inguinal metastases who are untreated rarely survive&#x000a0;2&#x000a0;years from the time of diagnosis.</p>
        <p>
<bold>Survival Estimate Based on Cancer Stage</bold>
</p>
        <p>Patients with stage I or II cancers, still confined to the penis at the time of diagnosis, have a 5-year survival rate of up to 85% after surgical management. Patients with stage III and IV cancers have an overall 5-year survival rate of around 59%. If cancer has metastasized to distant parts of the body, the 5-year survival rate is 11%.</p>
        <p>
<bold>Survival Estimate Based on Inguinal Lymph Node Status</bold>
</p>
        <p>Numerous studies have examined the extent of inguinal lymph node involvement as an indicator of survival. Results have shown that patients with no inguinal node metastases have an 85%&#x000a0;to 100% 5-year cancer-specific survival rate. Those with a single inguinal lymphatic metastasis have a 79% to 89% 5-year survival rate. Individuals with bilateral or multiple inguinal node metastases have a 17% to 60% 5-year survival rate,&#x000a0;whereas patients with pelvic node metastases have a 0% to 17% 5-year survival rate.<xref ref-type="bibr" rid="article-26896.r178">[178]</xref></p>
      </sec>
      <sec id="article-26896.s15" sec-type="Complications">
        <title>Complications</title>
        <p>Complications arising from penile cancer can significantly impact a patient's quality of life and treatment outcomes. These challenges highlight the importance of comprehensive management strategies in addressing the disease's physical and emotional ramifications.</p>
        <p>
<bold>Excision of the Primary Tumor</bold>
</p>
        <p>General complications of any surgery include infection, bleeding, and risks from receiving general anesthesia. The most common complication after penectomy is meatal stenosis.</p>
        <p>
<bold>Lymph Node Dissection Surgery</bold>
</p>
        <p>Inguinal lymph node dissection is a very morbid procedure and is the main reason for the reluctance to advocate automatic inguinal lymphadenectomy. Early complications include wound infections, flap necrosis, phlebitis, seroma, pulmonary embolism, and lymphedema of the scrotum and lower limbs. Wound infections and complications&#x000a0;are increased&#x000a0;in patients with morbid obesity (body mass index &#x02265;30), performing a pelvic lymph node dissection concomitantly, and longer operative times.<xref ref-type="bibr" rid="article-26896.r179">[179]</xref></p>
        <p>
<bold>Radiation Therapy</bold>
</p>
        <p>Complications are more frequent as the size of the tumor treated increases. Urethral strictures, local edema,&#x000a0;urethrocutaneous&#x000a0;fistulas, penile necrosis, phimosis, meatal stenosis, and pain are possible complications from this treatment.</p>
      </sec>
      <sec id="article-26896.s16" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Intensive follow-up should&#x000a0;be conducted&#x000a0;in patients after definitive therapy. Patients&#x000a0;are generally seen&#x000a0;approximately&#x000a0;2&#x000a0;weeks after the initial operative procedure to ensure a good recovery and&#x000a0;to initiate a surveillance protocol.<xref ref-type="bibr" rid="article-26896.r2">[2]</xref>&#x000a0;</p>
        <p>Recommended surveillance protocols include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients who undergo organ-sparing surgeries should be seen every&#x000a0;3&#x000a0;months for years 1 and 2, every&#x000a0;6&#x000a0;months for years 3 to 5, and annually for years 5 to 10. Follow-up should include a physical examination of the penis and inguinal nodes.</p>
          </list-item>
          <list-item>
            <p>Patients who undergo penectomy or partial penectomy should be seen every&#x000a0;6&#x000a0;months for the first&#x000a0;2&#x000a0;years and then yearly for years 3 to 5.</p>
          </list-item>
          <list-item>
            <p>Patients on active surveillance with clinically negative nodes should be seen every&#x000a0;3&#x000a0;months for the first&#x000a0;2&#x000a0;years and every&#x000a0;6&#x000a0;months for years 3 to 5.</p>
          </list-item>
          <list-item>
            <p>Patients who underwent inguinal lymph node dissections&#x000a0;staged&#x000a0;at N0 or N1 should be seen every&#x000a0;6&#x000a0;months for the first&#x000a0;3&#x000a0;years and yearly for years 3 to 5.</p>
          </list-item>
          <list-item>
            <p>Patients who underwent inguinal lymph node dissections and&#x000a0;were staged&#x000a0;at N2 or N3 should be seen every&#x000a0;3&#x000a0;months to 6 months for the first&#x000a0;2&#x000a0;years and yearly from years 3 to 5. They should have chest imaging (CT or chest x-ray) performed every&#x000a0;6&#x000a0;months for the first&#x000a0;2&#x000a0;years and a CT scan of the abdomen and pelvis performed every&#x000a0;3&#x000a0;months for the first year and every&#x000a0;6&#x000a0;months for the second year.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26896.s17" sec-type="Consultations">
        <title>Consultations</title>
        <p>A medical oncology consultation is appropriate if the patient is a candidate for neoadjuvant chemotherapy.&#x000a0;A radiation oncology consultation is appropriate for patients&#x000a0;proceeding with&#x000a0;radiation therapy to treat their primary tumor.&#x000a0;Poor prognosis indicators include a higher primary tumor stage, perineural invasion, basaloid or sarcomatoid histology, distant metastatic disease, and more extensive lymph nodal involvement. Patients with such indicators should receive a palliative care consult.&#x000a0;</p>
      </sec>
      <sec id="article-26896.s18" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should understand the importance of genital cleanliness and the association of poor hygiene with penile cancers. High-risk sexual behavior that puts&#x000a0;the patient at risk for HPV and HIV should&#x000a0;be discontinued, as well as tobacco use.&#x000a0;Most importantly, patients need to understand that any lesions on the penis must&#x000a0;be evaluated&#x000a0;by a clinician as soon as possible. Prompt diagnosis allows for intervention at an earlier stage with improved cosmetic and survival outcomes.&#x000a0;Enrollment in a clinical trial should be strongly encouraged, especially for patients with more advanced-stage disease.</p>
        <p>
<bold>The Debate Over Circumcision</bold>
</p>
        <p>Getting a clear presentation of the facts in favor and against newborn circumcision can be difficult. The recent trend has been to do fewer circumcisions in the United States. However, according to the National Center for Health Statistics, about two-thirds of newborn males still receive the procedure.&#x000a0;Pediatricians are often reluctant to perform the procedure as they tend to see the immediate adverse effects and complications (bleeding, infection, and pain), whereas urologists&#x000a0;tend to recommend it as they see the late consequences in uncircumcised adults (balanitis, phimosis, paraphimosis, and penile cancer).&#x000a0;Based on a recent extensive, evidence-based review of male circumcision, the relative benefits and drawbacks of the procedure are as follows:&#x000a0;</p>
        <p>
<bold>Benefits</bold>
</p>
        <p>Circumcision has&#x000a0;been found&#x000a0;to help protect men from balanitis,&#x000a0;balanoposthitis, candidiasis, inflammatory penile skin conditions, phimosis, paraphimosis, and STIs, as well as penile cancer.<xref ref-type="bibr" rid="article-26896.r19">[19]</xref>&#x000a0;Circumcision also improves a man's genital hygiene, which reduces the risk of STIs and cervical cancer in their women partners and avoids the need for a medically necessary but more complicated surgical procedure (dorsal slit or circumcision) later as adults.<xref ref-type="bibr" rid="article-26896.r22">[22]</xref><xref ref-type="bibr" rid="article-26896.r33">[33]</xref>&#x000a0;Balanoposthitis&#x000a0;is reported to affect 4% to 11% of all uncircumcised boys, whereas balanitis or&#x000a0;balanoposthitis&#x000a0;affects 3% or 6%, respectively, of all men worldwide.<xref ref-type="bibr" rid="article-26896.r19">[19]</xref>&#x000a0;More than 50% of uncircumcised men will have an adverse medical effect related to the foreskin at some point in their lives.<xref ref-type="bibr" rid="article-26896.r22">[22]</xref></p>
        <p>The reported complication rate of circumcision is 1.5%.<xref ref-type="bibr" rid="article-26896.r180">[180]</xref>&#x000a0;The procedure does not appear to have any provable effect on sexual sensitivity, activity, or satisfaction.<xref ref-type="bibr" rid="article-26896.r181">[181]</xref>&#x000a0;Circumcision&#x000a0;greatly&#x000a0;improves genital hygiene and eliminates smegma, which has a noticeably disagreeable odor even when uninfected. Local anesthesia (topical anesthetic cream, acetaminophen rectal suppositories, and direct local anesthetic injections) can minimize any patient discomfort, and neonatal circumcision virtually eliminates the risk of penile cancer developing later in life, when it can be a lethal and catastrophic disease.<xref ref-type="bibr" rid="article-26896.r21">[21]</xref><xref ref-type="bibr" rid="article-26896.r23">[23]</xref><xref ref-type="bibr" rid="article-26896.r24">[24]</xref></p>
        <p>
<bold>Drawbacks</bold>
</p>
        <p>Suggested&#x000a0;drawbacks of circumcisions include procedural&#x000a0;adverse effects, decreased social acceptability (it&#x02019;s&#x000a0;not &#x0201c;popular&#x0201d; anymore), loss of &#x0201c;protection&#x0201d; of the glans by the foreskin during infancy and childhood, the perception that it is a painful surgery which could have lingering emotional or psychological consequences, doing foreskin surgery is &#x0201c;unnatural,&#x0201d; that having an intact foreskin will provide greater sensitivity and increase male sexual satisfaction, and that the health benefits of circumcisions are overblown.&#x000a0;Too much or too little skin may&#x000a0;be removed, and some patients require additional surgical revision.<xref ref-type="bibr" rid="article-26896.r182">[182]</xref></p>
        <p>There is an estimation that it would take at least 1000 neonatal circumcisions or more to prevent&#x000a0;1&#x000a0;penile cancer.&#x000a0;While this is likely, it is still unproven that the increased use of HPV vaccines will reduce the incidence of penile cancer even without circumcision.<xref ref-type="bibr" rid="article-26896.r90">[90]</xref><xref ref-type="bibr" rid="article-26896.r183">[183]</xref>&#x000a0;Neonatal deaths from circumcisions have&#x000a0;been cited&#x000a0;as another reason to avoid the procedure, but no actual mortality statistics from any official government agency or medical professional society document this as the incidence is too low.&#x000a0;The overall risk-benefit analysis found that the proven benefits of circumcision far exceed the negatives by almost 200&#x000a0;to 1.<xref ref-type="bibr" rid="article-26896.r22">[22]</xref>&#x000a0;The American Academy of Pediatrics and the American Academy of Family Physicians agree that the benefits of circumcision far outweigh the risks.<xref ref-type="bibr" rid="article-26896.r184">[184]</xref>&#x000a0;However, this remains a controversial subject that&#x000a0;is often decided&#x000a0;by family circumcision history or religious practice.<xref ref-type="bibr" rid="article-26896.r185">[185]</xref></p>
        <p>The role of the healthcare team is to fully inform the family of the facts, both pros and cons. The parent's wishes on this subject should be respected unless medically contraindicated, so it&#x000a0;is recommended&#x000a0;that the family be provided with evidence-based factual information during the pregnancy, if possible, so they have the necessary time to consider their choice regarding circumcision carefully and to make an informed decision.&#x000a0;Neonatal circumcision can likely prevent painful deaths due to&#x000a0;penile cancer.<xref ref-type="bibr" rid="article-26896.r22">[22]</xref>&#x000a0;Although quite rare, it does not&#x000a0;require many such cases to convince clinicians of the overwhelming benefits of neonatal circumcision, even if only to essentially eliminate the admittedly small risk of penile cancer later in life.</p>
      </sec>
      <sec id="article-26896.s19" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Understanding key clinical pearls can enhance the management of penile cancer. These insights, ranging from risk factors to diagnostic techniques and treatment considerations, provide valuable guidance for healthcare professionals navigating this complex condition and are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Any penile skin lesion, ulcer, nodule, balanitis, or rash that does not improve with standard therapy should be considered suspicious for penile malignancy and subject to a biopsy.</p>
          </list-item>
          <list-item>
            <p>Syphilis can closely mimic early penile cancer clinically. Both may present as small, painless ulcers on the penis, and both may demonstrate lymphadenopathy. Unlike penile cancer, syphilitic lesions will heal even without treatment, and serological testing for syphilis (Venereal Disease Research Laboratory, rapid plasma reagin) will be positive.<xref ref-type="bibr" rid="article-26896.r186">[186]</xref></p>
          </list-item>
          <list-item>
            <p>Performing a biopsy that is ultimately negative is better than delaying a biopsy and only finding out the lesion is malignant after it has become more advanced and invasive.</p>
          </list-item>
          <list-item>
            <p>Evaluation of the regional lymph nodes is required for accurate staging and prognosis.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref></p>
          </list-item>
          <list-item>
            <p>Even normal-appearing lymph nodes may contain micrometastases up to 25% of the time.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref></p>
          </list-item>
          <list-item>
            <p>Treatment is based on the following principle: do as much surgical resection as necessary, but preserve as much as possible.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref></p>
          </list-item>
          <list-item>
            <p>If lymph node metastases are limited, lymphadenectomy surgery with adjuvant chemotherapy is potentially curative.<xref ref-type="bibr" rid="article-26896.r49">[49]</xref></p>
          </list-item>
          <list-item>
            <p>Tertiary care centers with experience in penile cancers will have better outcomes from DSNB and lymph node dissections.<xref ref-type="bibr" rid="article-26896.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26896.s20" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Penile cancer is a relatively uncommon malignancy in the United States. Unfortunately, its diagnosis is often delayed due to many factors, including patient embarrassment, denial, and misdiagnosis by primary care practitioners. If there is any concern about a penile lesion, the patient should be seen by a urologist or dermatologist as early in the workup as possible. Caregivers and members of the healthcare team should inspect the male genitalia regularly, especially in older uncircumcised males, as they are prone to some penile skin conditions, including malignancy. Managing penile cancer is primarily surgical, but early cases can be treated with minimally invasive therapies. Early-stage penile cancer has a good outcome, but advanced stages generally have a very poor prognosis.<xref ref-type="bibr" rid="article-26896.r109">[109]</xref></p>
        <p>The interprofessional team includes a primary care doctor or advanced care clinician, a urologist, a radiologist, a nuclear medicine physician, an oncologist, and specialty-trained nurses. The team may also include pediatricians in their discussions regarding the pros and cons of neonatal circumcisions.&#x000a0;Nurses assist in patient and family education, monitor patients, and report issues to the healthcare team. They also arrange close follow-ups when needed.</p>
        <p>Ethical considerations come into play when determining treatment options and respecting patient autonomy in decision-making. Responsibilities within the interprofessional team should be clearly defined, with each member contributing their specialized knowledge and skills to optimize patient care. Effective interprofessional communication fosters a collaborative environment where information is shared, questions are encouraged, and concerns are addressed promptly.</p>
        <p>Lastly, care coordination is pivotal in ensuring seamless and efficient patient care. Physicians, advanced care clinicians, nurses, pharmacists, and other healthcare professionals must work together to streamline the patient's journey, from diagnosis through treatment and follow-up. This coordination minimizes errors, reduces delays, and enhances patient safety, ultimately leading to improved outcomes and patient-centered care that prioritizes the well-being and satisfaction of those affected by penile cancer.</p>
      </sec>
      <sec id="article-26896.s21">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26896&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26896">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/penile-cancer-and-penile-intraepithelial-neoplasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26896">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26896/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26896">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26896.s22">
        <title>References</title>
        <ref id="article-26896.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skeppner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Windahl</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Initial symptoms and delay in patients with penile carcinoma.</article-title>
            <source>Scand J Urol Nephrol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>319</fpage>
            <page-range>319-25</page-range>
            <pub-id pub-id-type="pmid">22989150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brouwer</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>Albersen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parnham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Protzel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Ayres</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Antunes-Lopes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barreto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Campi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Crook</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Pello</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Greco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>van der Heijden</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>PAS</given-names>
              </name>
              <name>
                <surname>Kailavasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manzie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Osborne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Garcia-Perdomo</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Rumble</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sachdeva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sakalis</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Zapala</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez Mart&#x000ed;nez</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Tagawa</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update.</article-title>
            <source>Eur Urol</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>83</volume>
            <issue>6</issue>
            <fpage>548</fpage>
            <page-range>548-560</page-range>
            <pub-id pub-id-type="pmid">36906413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>XF</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ZJ</given-names>
              </name>
            </person-group>
            <article-title>Risk factors and negative consequences of patient's delay for penile carcinoma.</article-title>
            <source>World J Surg Oncol</source>
            <year>2016</year>
            <month>Apr</month>
            <day>27</day>
            <volume>14</volume>
            <fpage>124</fpage>
            <pub-id pub-id-type="pmid">27121955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ian Janes</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Henley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Organ</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A quality assurance review of penile cancer diagnostic delays and stage at presentation during the COVID-19 pandemic.</article-title>
            <source>Can Urol Assoc J</source>
            <year>2023</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>E134</fpage>
            <page-range>E134-E140</page-range>
            <pub-id pub-id-type="pmid">36758180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doherty</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bridge</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy.</article-title>
            <source>J Med Imaging Radiat Sci</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>171</fpage>
            <page-range>171-178</page-range>
            <pub-id pub-id-type="pmid">30777241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wheldon</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Krakow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Moser</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>National Trends in Human Papillomavirus Awareness and Knowledge of Human Papillomavirus-Related Cancers.</article-title>
            <source>Am J Prev Med</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>e117</fpage>
            <page-range>e117-e123</page-range>
            <pub-id pub-id-type="pmid">30772151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pohankov&#x000e1;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sir&#x000e1;k</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ka&#x00161;aov&#x000e1;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grepl</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paluska</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Louda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holub</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>&#x00160;pa&#x0010d;ek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pro&#x00161;vic</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petera</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>High-Dose Rate Brachyther-apy in the Treatment of Early Stages of Penile Carcinoma.</article-title>
            <source>Klin Onkol</source>
            <year>2019</year>
            <season>Winter</season>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-57</page-range>
            <pub-id pub-id-type="pmid">30764630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mrinakova</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ondru&#x00161;ov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x00160;vantnerov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ondru&#x00161;</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Malignant Tumors of the Penis - Dia-gnostics and Therapy.</article-title>
            <source>Klin Onkol</source>
            <year>2019</year>
            <season>Winter</season>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-39</page-range>
            <pub-id pub-id-type="pmid">30764627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chamli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zaouak</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Bowenoid Papulosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>9</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">30969709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <collab>PDQ Adult Treatment Editorial Board</collab>
            <chapter-title>Penile Cancer Treatment (PDQ&#x000ae;): Health Professional Version</chapter-title>
            <source>PDQ Cancer Information Summaries [Internet]</source>
            <publisher-name>National Cancer Institute (US)</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">26389381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slongo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giuliano</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>The relationship between HPV and penile cancer: Filling a knowledge gap in the general population.</article-title>
            <source>Can Urol Assoc J</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>38</fpage>
            <pub-id pub-id-type="pmid">30721126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamel</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Should the Care of Penile Cancer be Confined to Centralized Centers of Excellence?</article-title>
            <source>Eur Urol Focus</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>735</fpage>
            <page-range>735-736</page-range>
            <pub-id pub-id-type="pmid">30685355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hernandez</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Barnholtz-Sloan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>German</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Giuliano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Negoita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Villalon-Gomez</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003.</article-title>
            <source>Cancer</source>
            <year>2008</year>
            <month>Nov</month>
            <day>15</day>
            <volume>113</volume>
            <issue>10 Suppl</issue>
            <fpage>2883</fpage>
            <page-range>2883-91</page-range>
            <pub-id pub-id-type="pmid">18980292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douglawi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masterson</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Penile cancer epidemiology and risk factors: a contemporary review.</article-title>
            <source>Curr Opin Urol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-149</page-range>
            <pub-id pub-id-type="pmid">30562185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dillner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>von Krogh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Etiology of squamous cell carcinoma of the penis.</article-title>
            <source>Scand J Urol Nephrol Suppl</source>
            <year>2000</year>
            <issue>205</issue>
            <fpage>189</fpage>
            <page-range>189-93</page-range>
            <pub-id pub-id-type="pmid">11144896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larke</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>dos Santos Silva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Male circumcision and penile cancer: a systematic review and meta-analysis.</article-title>
            <source>Cancer Causes Control</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>1097</fpage>
            <page-range>1097-110</page-range>
            <pub-id pub-id-type="pmid">21695385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Castellsague</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>FX</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Waskett</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Hankins</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The Strong Protective Effect of Circumcision against Cancer of the Penis.</article-title>
            <source>Adv Urol</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>812368</fpage>
            <pub-id pub-id-type="pmid">21687572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Howe</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>The carcinogenicity of smegma: debunking a myth.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>9</issue>
            <fpage>1046</fpage>
            <page-range>1046-54</page-range>
            <pub-id pub-id-type="pmid">16987256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kojima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mizuno</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kohri</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Prepuce: phimosis, paraphimosis, and circumcision.</article-title>
            <source>ScientificWorldJournal</source>
            <year>2011</year>
            <month>Feb</month>
            <day>03</day>
            <volume>11</volume>
            <fpage>289</fpage>
            <page-range>289-301</page-range>
            <pub-id pub-id-type="pmid">21298220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afonso</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cordeiro</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Carestiato</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Ornellas</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cavalcanti</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>High Risk Human Papillomavirus Infection of the Foreskin in Asymptomatic Men and Patients with Phimosis.</article-title>
            <source>J Urol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>195</volume>
            <issue>6</issue>
            <fpage>1784</fpage>
            <page-range>1784-9</page-range>
            <pub-id pub-id-type="pmid">26796413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daling</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Madeleine</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Shera</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Wurscher</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Galloway</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>McDougall</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease.</article-title>
            <source>Int J Cancer</source>
            <year>2005</year>
            <month>Sep</month>
            <day>10</day>
            <volume>116</volume>
            <issue>4</issue>
            <fpage>606</fpage>
            <page-range>606-16</page-range>
            <pub-id pub-id-type="pmid">15825185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Katelaris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blumenthal</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Hajoona</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sheen</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Schrieber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lumbers</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Wodak</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Katelaris</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Evidence-based circumcision policy for Australia.</article-title>
            <source>J Mens Health</source>
            <year>2022</year>
            <volume>18</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">36034719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ornellas</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ornellas</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Should routine neonatal circumcision be a police to prevent penile cancer? | Opinion: Yes.</article-title>
            <source>Int Braz J Urol</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-9</page-range>
            <pub-id pub-id-type="pmid">28124519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LICKLIDER</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Jewish penile carcinoma.</article-title>
            <source>J Urol</source>
            <year>1961</year>
            <month>Jul</month>
            <volume>86</volume>
            <fpage>98</fpage>
            <pub-id pub-id-type="pmid">13761942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsen</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States).</article-title>
            <source>Cancer Causes Control</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-77</page-range>
            <pub-id pub-id-type="pmid">11405332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crocetto</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Arcaniolo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Barone</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>La Rocca</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Capece</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Imbimbo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Sio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calace</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Manfredi</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Impact of Sexual Activity on the Risk of Male Genital Tumors: A Systematic Review of the Literature.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2021</year>
            <month>Aug</month>
            <day>11</day>
            <volume>18</volume>
            <issue>16</issue>
            <pub-id pub-id-type="pmid">34444249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kidd</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Chaing</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chipollini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giuliano</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Relationship between human papillomavirus and penile cancer-implications for prevention and treatment.</article-title>
            <source>Transl Androl Urol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>791</fpage>
            <page-range>791-802</page-range>
            <pub-id pub-id-type="pmid">29184775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fenner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>HPV positivity and radiotherapy outcomes in PSCC.</article-title>
            <source>Nat Rev Urol</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <pub-id pub-id-type="pmid">33244177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lont</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Kroon</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gallee</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Berkhof</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meijer</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Snijders</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival.</article-title>
            <source>Int J Cancer</source>
            <year>2006</year>
            <month>Sep</month>
            <day>01</day>
            <volume>119</volume>
            <issue>5</issue>
            <fpage>1078</fpage>
            <page-range>1078-81</page-range>
            <pub-id pub-id-type="pmid">16570278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r30">
          <label>30</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Giona</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>The Epidemiology of Penile Cancer</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Barber</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>Urologic Cancers [Internet]</source>
            <publisher-name>Exon Publications</publisher-name>
            <publisher-loc>Brisbane (AU)</publisher-loc>
            <year>2022</year>
            <month>09</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">36343135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maden</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Beckmann</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hislop</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Teh</surname>
                <given-names>CZ</given-names>
              </name>
              <name>
                <surname>Ashley</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Daling</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>History of circumcision, medical conditions, and sexual activity and risk of penile cancer.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>1993</year>
            <month>Jan</month>
            <day>06</day>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-24</page-range>
            <pub-id pub-id-type="pmid">8380060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baldwin</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Papenfuss</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Abrahamsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vaught</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Giuliano</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic.</article-title>
            <source>Sex Transm Dis</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>601</fpage>
            <page-range>601-7</page-range>
            <pub-id pub-id-type="pmid">15388997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Douglawi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masterson</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Updates on the epidemiology and risk factors for penile cancer.</article-title>
            <source>Transl Androl Urol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>785</fpage>
            <page-range>785-790</page-range>
            <pub-id pub-id-type="pmid">29184774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massicotte-Azarniouch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Noel</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Knoll</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Cancer in Kidney Transplant Recipients.</article-title>
            <source>Semin Nephrol</source>
            <year>2024</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>151494</fpage>
            <pub-id pub-id-type="pmid">38538455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Archier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Devaux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Castela</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gallini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aubin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Ma&#x000ee;tre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aractingi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bachelez</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jullien</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Misery</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ortonne</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2012</year>
            <month>May</month>
            <volume>26 Suppl 3</volume>
            <fpage>22</fpage>
            <page-range>22-31</page-range>
            <pub-id pub-id-type="pmid">22512677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stern</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bagheri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>K</given-names>
              </name>
              <collab>PUVA Follow Up Study</collab>
            </person-group>
            <article-title>The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-9</page-range>
            <pub-id pub-id-type="pmid">12077578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nijsten</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998.</article-title>
            <source>Br J Dermatol</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>147</volume>
            <issue>1</issue>
            <fpage>184</fpage>
            <page-range>184-5; author reply 185-6</page-range>
            <pub-id pub-id-type="pmid">12100215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stern</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.</article-title>
            <source>N Engl J Med</source>
            <year>1990</year>
            <month>Apr</month>
            <day>19</day>
            <volume>322</volume>
            <issue>16</issue>
            <fpage>1093</fpage>
            <page-range>1093-7</page-range>
            <pub-id pub-id-type="pmid">2320078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teixeira J&#x000fa;nior</surname>
                <given-names>AAL</given-names>
              </name>
              <name>
                <surname>da Costa Melo</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Pinho</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sobrinho</surname>
                <given-names>TBM</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>TMS</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>DRD</given-names>
              </name>
              <name>
                <surname>de Oliveira Barbosa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>de Castro Belfort</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>da Silva Neto</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>de Ribamar Rodrigues Calixto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paiva Paiva</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>do Nascimento</surname>
                <given-names>FSMS</given-names>
              </name>
              <name>
                <surname>Alencar Junior</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Khayat</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>da Gra&#x000e7;a Carvalhal Fraz&#x000e3;o Corr&#x000ea;a</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lages</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Dos Reis</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Ara&#x000fa;jo</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>GEB</given-names>
              </name>
            </person-group>
            <article-title>A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease.</article-title>
            <source>BMC Cancer</source>
            <year>2022</year>
            <month>Oct</month>
            <day>15</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>1063</fpage>
            <pub-id pub-id-type="pmid">36243680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegel</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Wagle</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Jemal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Cancer statistics, 2023.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-48</page-range>
            <pub-id pub-id-type="pmid">36633525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnholtz-Sloan</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Maldonado</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Pow-sang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giuliano</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Incidence trends in primary malignant penile cancer.</article-title>
            <source>Urol Oncol</source>
            <year>2007</year>
            <season>Sep-Oct</season>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>361</fpage>
            <page-range>361-7</page-range>
            <pub-id pub-id-type="pmid">17826651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chipollini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De la Rosa</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shayegan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zorn</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Patient presentation, differential diagnosis, and management of penile lesions.</article-title>
            <source>Can Urol Assoc J</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2 Suppl 1</issue>
            <fpage>S2</fpage>
            <page-range>S2-S8</page-range>
            <pub-id pub-id-type="pmid">31237837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r43">
          <label>43</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mikhael</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Abdomen and Pelvis: Lymphatic Drainage</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">32491652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r44">
          <label>44</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bordoni</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Abdomen and Pelvis: Inguinal Lymph Node</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">32491571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Velazquez</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Chaux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cubilla</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Histologic classification of penile intraepithelial neoplasia.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2012</year>
            <month>May</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>96</fpage>
            <page-range>96-102</page-range>
            <pub-id pub-id-type="pmid">22641959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pfannl</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lloveras</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alejo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clavero</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lezcano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Sanjos&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-P&#x000e9;rez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Velazquez</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Cubilla</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>385</fpage>
            <page-range>385-92</page-range>
            <pub-id pub-id-type="pmid">20139761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Straub Hogan</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Spieker</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Orejudos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gheit</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Herfs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tommasino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Fernandez-Nestosa</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pena</surname>
                <given-names>MDCR</given-names>
              </name>
              <name>
                <surname>Gordetsky</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Epstein</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Canete-Portillo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gellert</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Prieto Granada</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Magi-Galluzzi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cubilla</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Giannico</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: a North American series.</article-title>
            <source>Mod Pathol</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>8</issue>
            <fpage>1101</fpage>
            <page-range>1101-1109</page-range>
            <pub-id pub-id-type="pmid">35190664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kristiansen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>&#x000c5;</given-names>
              </name>
              <name>
                <surname>Drevin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Forslund</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Torbrand</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bjartling</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors for Penile Intraepithelial Neoplasia: A Population-based Register Study in Sweden, 2000-2012.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-320</page-range>
            <pub-id pub-id-type="pmid">30426132</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hakenberg</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Dr&#x000e4;ger</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Erbersdobler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>J&#x000fc;nemann</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Protzel</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The Diagnosis and Treatment of Penile Cancer.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2018</year>
            <month>Sep</month>
            <day>28</day>
            <volume>115</volume>
            <issue>39</issue>
            <fpage>646</fpage>
            <page-range>646-652</page-range>
            <pub-id pub-id-type="pmid">30375327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cubilla</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Humphrey</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Reuter</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Ulbright</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.</article-title>
            <source>Eur Urol</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>70</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-105</page-range>
            <pub-id pub-id-type="pmid">26935559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Berney</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Cree</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Srigley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Tsuzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Comp&#x000e9;rat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Netto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Turajlic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Raspollini</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Tickoo</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>WHO 2022 classification of penile and scrotal cancers: updates and evolution.</article-title>
            <source>Histopathology</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>82</volume>
            <issue>4</issue>
            <fpage>508</fpage>
            <page-range>508-520</page-range>
            <pub-id pub-id-type="pmid">36221864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wikstr&#x000f6;m</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hedblad</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Syrj&#x000e4;nen</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>325</fpage>
            <page-range>325-30</page-range>
            <pub-id pub-id-type="pmid">21492254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritchie</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>S</given-names>
              </name>
              <collab>BAUS Section of Oncology</collab>
            </person-group>
            <article-title>Penile cancer in the UK: clinical presentation and outcome in 1998/99.</article-title>
            <source>BJU Int</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>9</issue>
            <fpage>1248</fpage>
            <page-range>1248-52</page-range>
            <pub-id pub-id-type="pmid">15610099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heyns</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Mendoza-Vald&#x000e9;s</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pompeo</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and staging of penile cancer.</article-title>
            <source>Urology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2 Suppl 1</issue>
            <fpage>S15</fpage>
            <page-range>S15-23</page-range>
            <pub-id pub-id-type="pmid">20691881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Halder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma of the penis metastasizing to the dorsal spine. A case report.</article-title>
            <source>Urol Int</source>
            <year>1999</year>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>249</fpage>
            <page-range>249-51</page-range>
            <pub-id pub-id-type="pmid">10567894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Purkayastha</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Multiple cutaneous metastasis from carcinoma of the penis-report of two cases.</article-title>
            <source>Indian J Surg Oncol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-5</page-range>
            <pub-id pub-id-type="pmid">24426703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joshi</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Handorf</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Correa</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Kutikov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DYT</given-names>
              </name>
              <name>
                <surname>Viterbo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Uzzo</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Smaldone</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Geynisman</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.</article-title>
            <source>JAMA Oncol</source>
            <year>2018</year>
            <month>May</month>
            <day>01</day>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>643</fpage>
            <page-range>643-649</page-range>
            <pub-id pub-id-type="pmid">29494739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Chia</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Management of penile cancer in a Singapore tertiary hospital.</article-title>
            <source>Arab J Urol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-130</page-range>
            <pub-id pub-id-type="pmid">29071141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Watchorn</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Panagou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Panou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Heelan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Haider</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bunker</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Dermatoscopic findings of penile intraepithelial neoplasia: Bowenoid papulosis, Bowen disease and erythroplasia of Queyrat.</article-title>
            <source>Australas J Dermatol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>e201</fpage>
            <page-range>e201-e207</page-range>
            <pub-id pub-id-type="pmid">30585302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petralia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scardino</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zoffoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Renne</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Cobelli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bellomi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection.</article-title>
            <source>Radiol Med</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>113</volume>
            <issue>4</issue>
            <fpage>517</fpage>
            <page-range>517-28</page-range>
            <pub-id pub-id-type="pmid">18478188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vries</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>Heijmink</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vegt</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Recent developments in penile cancer imaging.</article-title>
            <source>Curr Opin Urol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-155</page-range>
            <pub-id pub-id-type="pmid">30601182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chahoud</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer.</article-title>
            <source>Urol Clin North Am</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <page-range>145-150</page-range>
            <pub-id pub-id-type="pmid">36424078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r63">
          <label>63</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mulita</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lotfollahzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukkamalla</surname>
                <given-names>SKR</given-names>
              </name>
            </person-group>
            <chapter-title>Lymph Node Dissection</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">33232067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r64">
          <label>64</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sigmon</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Fatima</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Fine Needle Aspiration</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>5</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">32491418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Brien</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Teh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Chee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lawrentschuk</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dynamic Sentinel Lymph Node Biopsy for Penile Cancer: Accuracy is in the Technique.</article-title>
            <source>Urology</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>164</volume>
            <fpage>e308</fpage>
            <pub-id pub-id-type="pmid">35283135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Djajadiningrat</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Teertstra</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>van Werkhoven</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Boven</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound examination and fine needle aspiration cytology-useful for followup of the regional nodes in penile cancer?</article-title>
            <source>J Urol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>191</volume>
            <issue>3</issue>
            <fpage>652</fpage>
            <page-range>652-5</page-range>
            <pub-id pub-id-type="pmid">23994372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graafland</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Leijte</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s Olmos</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hoefnagel</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Teertstra</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.</article-title>
            <source>Eur Urol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>339</fpage>
            <page-range>339-45</page-range>
            <pub-id pub-id-type="pmid">19477581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Performance of 18F-FDG PET/CT for Lymph Node Staging in Penile Cancer.</article-title>
            <source>Clin Nucl Med</source>
            <year>2022</year>
            <month>May</month>
            <day>01</day>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>402</fpage>
            <page-range>402-408</page-range>
            <pub-id pub-id-type="pmid">35143458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edwards</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Bunker</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>van der Snoek</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>van der Meijden</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>2022 European guideline for the management of balanoposthitis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>1104</fpage>
            <page-range>1104-1117</page-range>
            <pub-id pub-id-type="pmid">36942977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r70">
          <label>70</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Charifa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Volner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oakley</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <chapter-title>Intraepidermal Carcinoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">29494081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikenberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gissmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grussendorf-Conen</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>zur Hausen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis.</article-title>
            <source>Int J Cancer</source>
            <year>1983</year>
            <month>Nov</month>
            <day>15</day>
            <volume>32</volume>
            <issue>5</issue>
            <fpage>563</fpage>
            <page-range>563-5</page-range>
            <pub-id pub-id-type="pmid">6315601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morton</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Birnie</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Eedy</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014.</article-title>
            <source>Br J Dermatol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>170</volume>
            <issue>2</issue>
            <fpage>245</fpage>
            <page-range>245-60</page-range>
            <pub-id pub-id-type="pmid">24313974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takayama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ishiguro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Coexistence of Bowenoid papulosis and Bowen's disease in a patient with systemic lupus erythematosus.</article-title>
            <source>J Dermatol</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>646</fpage>
            <page-range>646-9</page-range>
            <pub-id pub-id-type="pmid">22142328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonnekoh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mahrle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Steigleder</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>[Transition to cutaneous squamous cell carcinoma in 2 patients with bowenoid papulomatosis].</article-title>
            <source>Z Hautkr</source>
            <year>1987</year>
            <month>May</month>
            <day>15</day>
            <volume>62</volume>
            <issue>10</issue>
            <fpage>773</fpage>
            <page-range>773-6, 780-4</page-range>
            <pub-id pub-id-type="pmid">3039749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoneta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Iwasawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jimbow</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Development of squamous cell carcinoma by two high-risk human papillomaviruses (HPVs), a novel HPV-67 and HPV-31 from bowenoid papulosis.</article-title>
            <source>Br J Dermatol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>143</volume>
            <issue>3</issue>
            <fpage>604</fpage>
            <page-range>604-8</page-range>
            <pub-id pub-id-type="pmid">10971337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r76">
          <label>76</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Irshad</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Puckett</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <chapter-title>Giant Condylomata Acuminata of Buschke and Lowenstein</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">32809549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shabbir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Minhas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muneer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of premalignant penile lesions.</article-title>
            <source>Ther Adv Urol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>151</fpage>
            <page-range>151-8</page-range>
            <pub-id pub-id-type="pmid">21904571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertram</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Treutner</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>R&#x000fc;bben</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hauptmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schumpelick</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Invasive squamous-cell carcinoma in giant anorectal condyloma (Buschke-L&#x000f6;wenstein tumor).</article-title>
            <source>Langenbecks Arch Chir</source>
            <year>1995</year>
            <volume>380</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-8</page-range>
            <pub-id pub-id-type="pmid">7760649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>QD</given-names>
              </name>
              <name>
                <surname>Vezeridis</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Libbey</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Wanebo</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>37</volume>
            <issue>9</issue>
            <fpage>950</fpage>
            <page-range>950-7</page-range>
            <pub-id pub-id-type="pmid">8076499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowe</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>McCullough</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous horns of the penis: an approach to management. Case report and review of the literature.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1985</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>2 Pt 2</issue>
            <fpage>369</fpage>
            <page-range>369-73</page-range>
            <pub-id pub-id-type="pmid">4031162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solivan</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous horn of the penis: its association with squamous cell carcinoma and HPV-16 infection.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>5 Pt 2</issue>
            <fpage>969</fpage>
            <page-range>969-72</page-range>
            <pub-id pub-id-type="pmid">2172337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fields</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Drylie</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Malignant evolution of penile horn.</article-title>
            <source>Urology</source>
            <year>1987</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-6</page-range>
            <pub-id pub-id-type="pmid">3603912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassan</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Orteza</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Milam</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Penile horn: review of literature with 3 case reports.</article-title>
            <source>J Urol</source>
            <year>1967</year>
            <month>Feb</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-7</page-range>
            <pub-id pub-id-type="pmid">6018427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mikhail</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management.</article-title>
            <source>J Dermatol Surg Oncol</source>
            <year>1980</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>12</issue>
            <fpage>1027</fpage>
            <page-range>1027-35</page-range>
            <pub-id pub-id-type="pmid">6259230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schellhammer</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Robey</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Spaulding</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Premalignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum.</article-title>
            <source>Urol Clin North Am</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>131</fpage>
            <page-range>131-42</page-range>
            <pub-id pub-id-type="pmid">1736473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r86">
          <label>86</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Carocci</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>McIntosh</surname>
                <given-names>GV</given-names>
              </name>
            </person-group>
            <chapter-title>Balanitis Xerotica Obliterans</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>1</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">33620847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r87">
          <label>87</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chamli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Souissi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Lichen Sclerosus</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">30855834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbagli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Palminteri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mirri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guazzoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Turini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lazzeri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey.</article-title>
            <source>J Urol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>175</volume>
            <issue>4</issue>
            <fpage>1359</fpage>
            <page-range>1359-63</page-range>
            <pub-id pub-id-type="pmid">16515998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasca</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Innocenzi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Penile cancer among patients with genital lichen sclerosus.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>911</fpage>
            <page-range>911-4</page-range>
            <pub-id pub-id-type="pmid">10570372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czajkowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x0017b;awrocki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Czajkowska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>K&#x00142;&#x00105;cz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Soko&#x00142;owska-Wojdy&#x00142;o</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Biernat</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Matuszewski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lichen Sclerosus and Phimosis - Discrepancies Between Clinical and Pathological Diagnosis and Its Consequences.</article-title>
            <source>Urology</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>148</volume>
            <fpage>274</fpage>
            <page-range>274-279</page-range>
            <pub-id pub-id-type="pmid">33248142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r91">
          <label>91</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wray</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Velasquez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Khetarpal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Balanitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>8</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">30725828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bargman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pseudoepitheliomatous, keratotic, and micaceous balanitis.</article-title>
            <source>Cutis</source>
            <year>1985</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-9</page-range>
            <pub-id pub-id-type="pmid">3967518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salloum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bazzi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bachour</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>M&#x000e9;garban&#x000e9;</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pseudoepitheliomatous keratotic and micaceous balanitis: A literature review.</article-title>
            <source>Australas J Dermatol</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>421</fpage>
            <page-range>421-426</page-range>
            <pub-id pub-id-type="pmid">34129246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adya</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Palit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Inamadar</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Pseudoepitheliomatous keratotic and micaceous balanitis.</article-title>
            <source>Indian J Sex Transm Dis AIDS</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-5</page-range>
            <pub-id pub-id-type="pmid">24339464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Child</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Ganesan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Southern</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Herrington</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Calonje</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Verrucous carcinoma arising in pseudoepitheliomatous keratotic and micaceous balanitis, without evidence of human papillomavirus.</article-title>
            <source>Br J Dermatol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>143</volume>
            <issue>1</issue>
            <fpage>183</fpage>
            <page-range>183-7</page-range>
            <pub-id pub-id-type="pmid">10886158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gray</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ansell</surname>
                <given-names>ID</given-names>
              </name>
            </person-group>
            <article-title>Pseudo-epitheliomatous hyperkeratotic and micaceous balanitis: evidence for regarding it as pre-malignant.</article-title>
            <source>Br J Urol</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-4</page-range>
            <pub-id pub-id-type="pmid">2393789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beljaards</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hausman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Is pseudoepitheliomatous, micaceous and keratotic balanitis synonymous with verrucous carcinoma?</article-title>
            <source>Br J Dermatol</source>
            <year>1987</year>
            <month>Nov</month>
            <volume>117</volume>
            <issue>5</issue>
            <fpage>641</fpage>
            <page-range>641-6</page-range>
            <pub-id pub-id-type="pmid">3689682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanumaiah</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
              </name>
              <name>
                <surname>Lingaiah</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Kumaraswamy</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Vijaya</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pseudoepitheliomatous keratotic and micaceous balanitis: a rare condition successfully treated with topical 5-Fluorouracil.</article-title>
            <source>Indian J Dermatol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>58</volume>
            <issue>6</issue>
            <fpage>492</fpage>
            <pub-id pub-id-type="pmid">24249909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alnajjar</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bolgeri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.</article-title>
            <source>Eur Urol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>923</fpage>
            <page-range>923-8</page-range>
            <pub-id pub-id-type="pmid">22421082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minhas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Manseck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Watya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hegarty</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Penile cancer--prevention and premalignant conditions.</article-title>
            <source>Urology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2 Suppl 1</issue>
            <fpage>S24</fpage>
            <page-range>S24-35</page-range>
            <pub-id pub-id-type="pmid">20691883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r101">
          <label>101</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Prickett</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <chapter-title>Mohs Micrographic Surgery</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">28722863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manjunath</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brenton</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wylie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Corbishley</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity.</article-title>
            <source>Transl Androl Urol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>803</fpage>
            <page-range>803-808</page-range>
            <pub-id pub-id-type="pmid">29184776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lucky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Sangar</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Parr</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>The treatment of penile carcinoma in situ (CIS) within a UK supra-regional network.</article-title>
            <source>BJU Int</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>115</volume>
            <issue>4</issue>
            <fpage>595</fpage>
            <page-range>595-8</page-range>
            <pub-id pub-id-type="pmid">25060513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Burdon-Jones</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Imiquimod in the treatment of penile intraepithelial neoplasia: An update.</article-title>
            <source>Australas J Dermatol</source>
            <year>2017</year>
            <month>May</month>
            <volume>58</volume>
            <issue>2</issue>
            <fpage>86</fpage>
            <page-range>86-92</page-range>
            <pub-id pub-id-type="pmid">26952903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tietjen</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Malek</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Laser therapy of squamous cell dysplasia and carcinoma of the penis.</article-title>
            <source>Urology</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>559</fpage>
            <page-range>559-65</page-range>
            <pub-id pub-id-type="pmid">9763071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The acetowhite test in genital human papillomavirus infection in men: what does it add?</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-9</page-range>
            <pub-id pub-id-type="pmid">11451317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kristiansen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Torbrand</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>&#x000c5;</given-names>
              </name>
              <name>
                <surname>Forslund</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bjartling</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019.</article-title>
            <source>BJU Int</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>752</fpage>
            <page-range>752-759</page-range>
            <pub-id pub-id-type="pmid">35044047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kravvas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ge</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Doiron</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Watchorn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kentley</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Panou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dinneen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jameson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haider</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Minhas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alnajjar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Muneer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bunker</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>1047</fpage>
            <page-range>1047-1062</page-range>
            <pub-id pub-id-type="pmid">32705920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raskin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Vanthoor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milenkovic</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Muneer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Albersen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Organ-sparing surgical and nonsurgical modalities in primary penile cancer treatment.</article-title>
            <source>Curr Opin Urol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-164</page-range>
            <pub-id pub-id-type="pmid">30601184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chipollini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ottenhof</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Draeger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baumgarten</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Protzel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hakenberg</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature.</article-title>
            <source>BJU Int</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>121</volume>
            <issue>3</issue>
            <fpage>393</fpage>
            <page-range>393-398</page-range>
            <pub-id pub-id-type="pmid">28972681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crook</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grimard</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Radiation therapy in the management of the primary penile tumor: an update.</article-title>
            <source>World J Urol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>189</fpage>
            <page-range>189-96</page-range>
            <pub-id pub-id-type="pmid">18636264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escande</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haie-Meder</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mazeron</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maroun</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cavalcanti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Crevoisier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schernberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marsolat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Blanchard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Martinetti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dumas</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Deutsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chargari</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2017</year>
            <month>Nov</month>
            <day>01</day>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>563</fpage>
            <page-range>563-570</page-range>
            <pub-id pub-id-type="pmid">28501419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzocaro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Piva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bandieramonte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tana</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Up-to-date management of carcinoma of the penis.</article-title>
            <source>Eur Urol</source>
            <year>1997</year>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-15</page-range>
            <pub-id pub-id-type="pmid">9266225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delannes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malavaud</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Douchez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bonnet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Iridium-192 interstitial therapy for squamous cell carcinoma of the penis.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1992</year>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>479</fpage>
            <page-range>479-83</page-range>
            <pub-id pub-id-type="pmid">1399733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerbaulet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Radiation therapy of cancer of the penis. Indications, advantages, and pitfalls.</article-title>
            <source>Urol Clin North Am</source>
            <year>1992</year>
            <month>May</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>325</fpage>
            <page-range>325-32</page-range>
            <pub-id pub-id-type="pmid">1574823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaushal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Carcinoma of the penis. A 12-year review.</article-title>
            <source>Acta Oncol</source>
            <year>1987</year>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>413</fpage>
            <page-range>413-7</page-range>
            <pub-id pub-id-type="pmid">3446239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Issa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sebro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kwok</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Janisch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Grossmann</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parnham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sangar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fankhauser</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Treatment Options and Outcomes for Men with Penile Intraepithelial Neoplasia: A Systematic Review.</article-title>
            <source>Eur Urol Focus</source>
            <year>2022</year>
            <month>May</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>829</fpage>
            <page-range>829-832</page-range>
            <pub-id pub-id-type="pmid">33994168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shindel</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Lev</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Sengelmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hruza</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Brandes</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Mohs micrographic surgery for penile cancer: management and long-term followup.</article-title>
            <source>J Urol</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>178</volume>
            <issue>5</issue>
            <fpage>1980</fpage>
            <page-range>1980-5</page-range>
            <pub-id pub-id-type="pmid">17869306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alcal&#x000e1;</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Reines</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Merritt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Figler</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Bjurlin</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Mohs microsurgery for localized penile carcinoma: 10 year retrospective review of local recurrence rates and surgical complications.</article-title>
            <source>Urol Oncol</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>10</issue>
            <fpage>457.e1</fpage>
            <page-range>457.e1-457.e7</page-range>
            <pub-id pub-id-type="pmid">36088244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nister</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Melo</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Galvis</surname>
                <given-names>JAG</given-names>
              </name>
              <name>
                <surname>E Sousa</surname>
                <given-names>DDW</given-names>
              </name>
              <name>
                <surname>Tavares</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Maciel</surname>
                <given-names>CVM</given-names>
              </name>
            </person-group>
            <article-title>Case report: Penile cancer treated by Mohs micrographic surgery.</article-title>
            <source>Urol Case Rep</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>34</volume>
            <fpage>101441</fpage>
            <pub-id pub-id-type="pmid">33102127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assaf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sarkis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lilly</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ghazi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarkis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stephan</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Latest updates in Mohs micrographic surgery for the management of penile squamous cell carcinoma.</article-title>
            <source>Int J Dermatol</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>61</volume>
            <issue>9</issue>
            <fpage>e339</fpage>
            <page-range>e339-e342</page-range>
            <pub-id pub-id-type="pmid">35388468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lukowiak</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Perz</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Aizman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kovell</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Kovach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Krausz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Sobanko</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Etzkorn</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chelluri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Guzzo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Mohs micrographic surgery for male genital tumors: Local recurrence rates and patient-reported outcomes.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>1030</fpage>
            <page-range>1030-1036</page-range>
            <pub-id pub-id-type="pmid">33279645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Inman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors.</article-title>
            <source>Eur Urol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-6</page-range>
            <pub-id pub-id-type="pmid">28131464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frimberger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hungerhuber</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zaak</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Waidelich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hofstetter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schneede</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Penile carcinoma. Is Nd:YAG laser therapy radical enough?</article-title>
            <source>J Urol</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>168</volume>
            <issue>6</issue>
            <fpage>2418</fpage>
            <page-range>2418-21; discussion 2421</page-range>
            <pub-id pub-id-type="pmid">12441930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lont</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Gallee</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Meinhardt</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>van Tinteren</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence.</article-title>
            <source>J Urol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>176</volume>
            <issue>2</issue>
            <fpage>575</fpage>
            <page-range>575-80; discussion 580</page-range>
            <pub-id pub-id-type="pmid">16813892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ottenhof</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Draeger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baumgarten</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Chipollini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Protzel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hakenberg</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Laser ablation as monotherapy for penile squamous cell carcinoma: A multi-center cohort analysis.</article-title>
            <source>Urol Oncol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>147</fpage>
            <page-range>147-152</page-range>
            <pub-id pub-id-type="pmid">29097087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skeppner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Windahl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Andersson</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Fugl-Meyer</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma.</article-title>
            <source>Eur Urol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>631</fpage>
            <page-range>631-9</page-range>
            <pub-id pub-id-type="pmid">18788122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mercuri</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Paolino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brianti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Nicola</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montorsi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2022</year>
            <season>May-Aug</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>210</fpage>
            <page-range>210-213</page-range>
            <pub-id pub-id-type="pmid">36158859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadway</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Corbishley</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Total glans resurfacing for premalignant lesions of the penis: initial outcome data.</article-title>
            <source>BJU Int</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>3</issue>
            <fpage>532</fpage>
            <page-range>532-6</page-range>
            <pub-id pub-id-type="pmid">16925748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falcone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Preto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oderda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Timpano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Capogrosso</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cocci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fode</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gontero</surname>
                <given-names>P</given-names>
              </name>
              <collab>EAU-YAU Men's Health Working Group</collab>
            </person-group>
            <article-title>Total Glans Resurfacing for the Management of Superficial Penile Cancer: A Retrospective Cohort Analysis in a Tertiary Referral Center.</article-title>
            <source>Urology</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>145</volume>
            <fpage>281</fpage>
            <page-range>281-286</page-range>
            <pub-id pub-id-type="pmid">32683069</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shabbir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muneer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kalsi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Zacharakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Garaffa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ralph</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Minhas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes.</article-title>
            <source>Eur Urol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-7</page-range>
            <pub-id pub-id-type="pmid">21050658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Kelly</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lonergan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lundon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nason</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cullen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hegarty</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A Prospective Study of Total Glans Resurfacing for Localized Penile Cancer to Maximize Oncologic and Functional Outcomes in a Tertiary Referral Network.</article-title>
            <source>J Urol</source>
            <year>2017</year>
            <month>May</month>
            <volume>197</volume>
            <issue>5</issue>
            <fpage>1258</fpage>
            <page-range>1258-1263</page-range>
            <pub-id pub-id-type="pmid">28027867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Falcone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blecher</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Capece</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cocci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Timpano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gontero</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Functional and Patient Reported Outcomes Following Total Glans Resurfacing.</article-title>
            <source>J Sex Med</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>1099</fpage>
            <page-range>1099-1103</page-range>
            <pub-id pub-id-type="pmid">33935017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ranjan</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Ghorai</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Panwar</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Kundal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Modified "parachute technique" of partial penectomy: A penile preservation surgery for carcinoma penis.</article-title>
            <source>J Family Med Prim Care</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>1054</fpage>
            <page-range>1054-1056</page-range>
            <pub-id pub-id-type="pmid">34041123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Important Therapeutic Considerations in T1b Penile Cancer: Prognostic Significance and Adherence to Treatment Guidelines.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>685</fpage>
            <page-range>685-691</page-range>
            <pub-id pub-id-type="pmid">30565040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loughlin</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of penile carcinoma: the primary lesion.</article-title>
            <source>BJU Int</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>97</volume>
            <issue>3</issue>
            <fpage>655</fpage>
            <page-range>655-67</page-range>
            <pub-id pub-id-type="pmid">16469049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sachdeva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGuinness</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zapala</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>Greco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garcia-Perdomo</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Kailavasan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Antunes-Lopes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ayres</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barreto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Campi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Crook</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Manzie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Osborne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Protzel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bryan Rumble</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez Mart&#x000ed;nez</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Tagawa</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>van der Heijden</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Parnham</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Albersen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sangar</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>Sakalis</surname>
                <given-names>VI</given-names>
              </name>
            </person-group>
            <article-title>Management of Lymph Node-positive Penile Cancer: A Systematic Review.</article-title>
            <source>Eur Urol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>85</volume>
            <issue>3</issue>
            <fpage>257</fpage>
            <page-range>257-273</page-range>
            <pub-id pub-id-type="pmid">37208237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kathiresan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Raja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramachandran</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Sundersingh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Role of dynamic sentinel node biopsy in carcinoma penis with or without palpable nodes.</article-title>
            <source>Indian J Urol</source>
            <year>2016</year>
            <season>Jan-Mar</season>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-60</page-range>
            <pub-id pub-id-type="pmid">26941496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadeghi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gholami</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zakavi</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kakhki</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Tabasi</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta-analysis of the literature.</article-title>
            <source>J Urol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>187</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-31</page-range>
            <pub-id pub-id-type="pmid">22088350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graafland</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Leijte</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Yap</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gallee</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Corbishley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>van Werkhoven</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients.</article-title>
            <source>Eur Urol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>742</fpage>
            <page-range>742-7</page-range>
            <pub-id pub-id-type="pmid">20800339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Master</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Jafri</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ogan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kooby</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Delman</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications.</article-title>
            <source>J Urol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>188</volume>
            <issue>4</issue>
            <fpage>1176</fpage>
            <page-range>1176-80</page-range>
            <pub-id pub-id-type="pmid">22901575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r142">
          <label>142</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwentner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Todenh&#x000f6;fer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Seibold</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alloussi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Mischinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aufderklamm</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stenzl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gakis</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic inguinofemoral lymphadenectomy--extended follow-up.</article-title>
            <source>J Endourol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>497</fpage>
            <page-range>497-503</page-range>
            <pub-id pub-id-type="pmid">23067251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r143">
          <label>143</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jaipuria</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhardwaj</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baidya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rawal</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Comparing Outcomes of Robotic and Open Inguinal Lymph Node Dissection in Patients with Carcinoma of the Penis.</article-title>
            <source>J Urol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>199</volume>
            <issue>6</issue>
            <fpage>1518</fpage>
            <page-range>1518-1525</page-range>
            <pub-id pub-id-type="pmid">29307685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r144">
          <label>144</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gkegkes</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Minis</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Iavazzo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Robotic-assisted inguinal lymphadenectomy: a systematic review.</article-title>
            <source>J Robot Surg</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">29730734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r145">
          <label>145</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Salunke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bakshi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jayaprakash</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Robotic-Assisted Video-Endoscopic Inguinal Lymphadenectomy (RAVEIL) and Video-Endoscopic Inguinal Lymphadenectomy (VEIL) versus Open Inguinal Lymph-Node Dissection (OILND) in carcinoma of penis: Comparison of perioperative outcomes, complications and oncological outcomes. A systematic review and meta-analysis.</article-title>
            <source>Urol Oncol</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>112.e11</fpage>
            <page-range>112.e11-112.e22</page-range>
            <pub-id pub-id-type="pmid">34895995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r146">
          <label>146</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nerli</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ghagane</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hiremath</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Dixit</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Modified Inguinal Lymph Node Dissection in Groin-Negative Patients of Penile Cancer: Our Experience.</article-title>
            <source>Indian J Surg Oncol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>229</fpage>
            <page-range>229-234</page-range>
            <pub-id pub-id-type="pmid">33814858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r147">
          <label>147</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Duncan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Qu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Narasimhan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lawrentschuk</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Inguinal lymph node dissection for penile cancer: a contemporary review.</article-title>
            <source>Transl Androl Urol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>3210</fpage>
            <page-range>3210-3218</page-range>
            <pub-id pub-id-type="pmid">33457292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r148">
          <label>148</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Izawa</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Bassett</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kedar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Busby</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Eddings</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tamboli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation.</article-title>
            <source>J Urol</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>177</volume>
            <issue>6</issue>
            <fpage>2157</fpage>
            <page-range>2157-61</page-range>
            <pub-id pub-id-type="pmid">17509308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r149">
          <label>149</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hakenberg</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Comp&#x000e9;rat</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Minhas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Protzel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>EAU guidelines on penile cancer: 2014 update.</article-title>
            <source>Eur Urol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-150</page-range>
            <pub-id pub-id-type="pmid">25457021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r150">
          <label>150</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rieken</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Djajadiningrat</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kluth</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Favaretto</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Xylinas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guimaraes</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sjoberg</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shariat</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis.</article-title>
            <source>Eur Urol</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>811</fpage>
            <page-range>811-4</page-range>
            <pub-id pub-id-type="pmid">24924553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r151">
          <label>151</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leijte</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kirrander</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Antonini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Windahl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients.</article-title>
            <source>Eur Urol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>161</fpage>
            <page-range>161-8</page-range>
            <pub-id pub-id-type="pmid">18440124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r152">
          <label>152</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ottenhof</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Doodeman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vrijenhoek</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>van der Noort</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Donswijk</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>de Feijter</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schaake</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Horenblas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>van der Heijden</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Pos</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile Carcinoma.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2023</year>
            <month>Sep</month>
            <day>01</day>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>139</fpage>
            <page-range>139-147</page-range>
            <pub-id pub-id-type="pmid">37030606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r153">
          <label>153</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Theodore</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer.</article-title>
            <source>Urology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2 Suppl 1</issue>
            <fpage>S58</fpage>
            <page-range>S58-65</page-range>
            <pub-id pub-id-type="pmid">20691886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r154">
          <label>154</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hadian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <chapter-title>Cutaneous Squamous Cell Carcinoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>7</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">28722968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r155">
          <label>155</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Fagan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <chapter-title>Basal Cell Cancer</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">29261882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r156">
          <label>156</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gruber</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zito</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <chapter-title>Skin Cancer</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">28722978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r157">
          <label>157</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Heistein</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mukkamalla</surname>
                <given-names>SKR</given-names>
              </name>
            </person-group>
            <chapter-title>Malignant Melanoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">29262210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r158">
          <label>158</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Popovich</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gasalberti</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Cassaro</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Sarcoma</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">30137818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r159">
          <label>159</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leis-Dosil</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Alijo-Serrano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aviles-Izquierdo</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Lazaro-Ochaita</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lecona-Echeverria</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Angiokeratoma of the glans penis: clinical, histopathological and dermoscopic correlation.</article-title>
            <source>Dermatol Online J</source>
            <year>2007</year>
            <month>May</month>
            <day>01</day>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">17498438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r160">
          <label>160</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Perkins</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Cortes</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Balanoposthitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">31971711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r161">
          <label>161</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Ornellas</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ayres</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hakenberg</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Heidenreich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salvioni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Catanzaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raggi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Giannatempo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marandino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Haidl</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pederzoli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Briganti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montorsi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chipollini</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Meerleer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>Grass</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Albersen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma.</article-title>
            <source>Eur Urol Oncol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>802</fpage>
            <page-range>802-810</page-range>
            <pub-id pub-id-type="pmid">33199252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r162">
          <label>162</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marconi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>MacPepple</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hakenberg</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Watkin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>MacLennan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adewuyi</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Coscione</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Minhas</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Comp&#x000e9;rat</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel.</article-title>
            <source>Eur Urol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <page-range>76-83</page-range>
            <pub-id pub-id-type="pmid">29703686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r163">
          <label>163</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McComas</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maughan</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Tward</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Definitive Chemoradiotherapy for Locally Advanced, Lymph-node Positive, Nonmetastatic Penile Squamous Cell Carcinoma.</article-title>
            <source>Clin Genitourin Cancer</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>e573</fpage>
            <page-range>e573-e584</page-range>
            <pub-id pub-id-type="pmid">32335061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r164">
          <label>164</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Daliani</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Osai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kincaid</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thall</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.</article-title>
            <source>J Clin Oncol</source>
            <year>2010</year>
            <month>Aug</month>
            <day>20</day>
            <volume>28</volume>
            <issue>24</issue>
            <fpage>3851</fpage>
            <page-range>3851-7</page-range>
            <pub-id pub-id-type="pmid">20625118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r165">
          <label>165</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickstein</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Munsell</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy.</article-title>
            <source>BJU Int</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>118</fpage>
            <page-range>118-25</page-range>
            <pub-id pub-id-type="pmid">25294319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r166">
          <label>166</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Lorenzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Buonerba</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Federico</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Perdon&#x000e0;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aieta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rescigno</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>D'Aniello</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Puglia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Petremolo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marinelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palmieri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sonpavde</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mirone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Placido</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.</article-title>
            <source>BJU Int</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>110</volume>
            <issue>11 Pt B</issue>
            <fpage>E661</fpage>
            <page-range>E661-6</page-range>
            <pub-id pub-id-type="pmid">22958571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r167">
          <label>167</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bermejo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Busby</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma.</article-title>
            <source>J Urol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>177</volume>
            <issue>4</issue>
            <fpage>1335</fpage>
            <page-range>1335-8</page-range>
            <pub-id pub-id-type="pmid">17382727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r168">
          <label>168</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes.</article-title>
            <source>Urology</source>
            <year>2015</year>
            <month>May</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>1104</fpage>
            <page-range>1104-1110</page-range>
            <pub-id pub-id-type="pmid">25819619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r169">
          <label>169</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chahoud</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Skelton</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Spiess</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Walko</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dhillon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gage</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Johnstone</surname>
                <given-names>PAS</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab.</article-title>
            <source>Front Oncol</source>
            <year>2020</year>
            <volume>10</volume>
            <fpage>615298</fpage>
            <pub-id pub-id-type="pmid">33425770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r170">
          <label>170</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Necchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nicolai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Colecchia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Catanzaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Torelli</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Piva</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvioni</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.</article-title>
            <source>J Clin Oncol</source>
            <year>2011</year>
            <month>Aug</month>
            <day>01</day>
            <volume>29</volume>
            <issue>22</issue>
            <fpage>e650</fpage>
            <page-range>e650-2</page-range>
            <pub-id pub-id-type="pmid">21632506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r171">
          <label>171</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carthon</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Pettaway</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Pagliaro</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.</article-title>
            <source>BJU Int</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>113</volume>
            <issue>6</issue>
            <fpage>871</fpage>
            <page-range>871-7</page-range>
            <pub-id pub-id-type="pmid">24053151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r172">
          <label>172</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Udager</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Skala</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Magers</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McDaniel</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Spratt</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Fields</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Palapattu</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Weizer</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Chinnaiyan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Alva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Tomlins</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mehra</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.</article-title>
            <source>Ann Oncol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>9</issue>
            <fpage>1706</fpage>
            <page-range>1706-12</page-range>
            <pub-id pub-id-type="pmid">27217541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r173">
          <label>173</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lawen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Spooner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Faria</surname>
                <given-names>KVM</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ramasamy</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Approaches to Penile Cancer: Standards of Care and Recent Developments.</article-title>
            <source>Res Rep Urol</source>
            <year>2023</year>
            <volume>15</volume>
            <fpage>165</fpage>
            <page-range>165-174</page-range>
            <pub-id pub-id-type="pmid">37288454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r174">
          <label>174</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sakalihasan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fr&#x000e8;res</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Withofs</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sautois</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer.</article-title>
            <source>Case Rep Oncol</source>
            <year>2021</year>
            <season>May-Aug</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>972</fpage>
            <page-range>972-976</page-range>
            <pub-id pub-id-type="pmid">34267641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r175">
          <label>175</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchez</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Fernandez-Nestosa</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Canete-Portillo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cubilla</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>What Is New in the Pathologic Staging of Penile Carcinoma in the 8th Edition of AJCC TNM Model: Rationale for Changes With Practical Stage-by-stage Category Diagnostic Considerations.</article-title>
            <source>Adv Anat Pathol</source>
            <year>2021</year>
            <month>Jul</month>
            <day>01</day>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>209</fpage>
            <page-range>209-227</page-range>
            <pub-id pub-id-type="pmid">34050061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r176">
          <label>176</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haresh</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Sahoo</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaushal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Batra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical Profile and Predictors of Survival in Carcinoma Penis Patients.</article-title>
            <source>Curr Oncol</source>
            <year>2023</year>
            <month>Apr</month>
            <day>28</day>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>4563</fpage>
            <page-range>4563-4574</page-range>
            <pub-id pub-id-type="pmid">37232803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r177">
          <label>177</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkatout</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hedderich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hegele</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bolenz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>J&#x000fc;nemann</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Kl&#x000f6;ppel</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination.</article-title>
            <source>Urol Oncol</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>774</fpage>
            <page-range>774-81</page-range>
            <pub-id pub-id-type="pmid">20060332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r178">
          <label>178</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ficarra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Akduman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bouchot</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Palou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tobias-Machado</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in penile cancer.</article-title>
            <source>Urology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>76</volume>
            <issue>2 Suppl 1</issue>
            <fpage>S66</fpage>
            <page-range>S66-73</page-range>
            <pub-id pub-id-type="pmid">20691887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r179">
          <label>179</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chua</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Balraj</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Doppalapudi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Elsamra</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ghodoussipour</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Wound Complication Rates after Inguinal Lymph Node Dissection: Contemporary Analysis of the NSQIP Database.</article-title>
            <source>J Am Coll Surg</source>
            <year>2023</year>
            <month>Jan</month>
            <day>01</day>
            <volume>236</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-25</page-range>
            <pub-id pub-id-type="pmid">36519902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r180">
          <label>180</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Larke</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schenker</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Complications of circumcision in male neonates, infants and children: a systematic review.</article-title>
            <source>BMC Urol</source>
            <year>2010</year>
            <month>Feb</month>
            <day>16</day>
            <volume>10</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">20158883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r181">
          <label>181</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Does male circumcision affect sexual function, sensitivity, or satisfaction?--a systematic review.</article-title>
            <source>J Sex Med</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>11</issue>
            <fpage>2644</fpage>
            <page-range>2644-57</page-range>
            <pub-id pub-id-type="pmid">23937309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r182">
          <label>182</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Warees</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Anand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <chapter-title>Circumcision</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">30571057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r183">
          <label>183</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention (CDC)</collab>
            <article-title>Human papillomavirus-associated cancers - United States, 2004-2008.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2012</year>
            <month>Apr</month>
            <day>20</day>
            <volume>61</volume>
            <fpage>258</fpage>
            <page-range>258-61</page-range>
            <pub-id pub-id-type="pmid">22513527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r184">
          <label>184</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Urologic Conditions in Infants and Children: Circumcision.</article-title>
            <source>FP Essent</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>488</volume>
            <fpage>11</fpage>
            <page-range>11-15</page-range>
            <pub-id pub-id-type="pmid">31894950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r185">
          <label>185</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petersiel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yahalomi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neuberger</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pros and cons of circumcision: an evidence-based overview.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>9</issue>
            <fpage>768</fpage>
            <page-range>768-774</page-range>
            <pub-id pub-id-type="pmid">27497811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26896.r186">
          <label>186</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Tudor</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Al Aboud</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Gossman</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <chapter-title>Syphilis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>8</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30521201</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
